Electrosurgical seal and dissection systems

Information

  • Patent Grant
  • 10792092
  • Patent Number
    10,792,092
  • Date Filed
    Tuesday, October 25, 2016
    7 years ago
  • Date Issued
    Tuesday, October 6, 2020
    3 years ago
Abstract
A bipolar electrosurgical fusion/sealer and dissector is provided that is arranged to simultaneously fuse and cut tissue captured between jaws of the instrument. The jaws include particularly positioned, shaped and/or oriented electrodes along with a compressible landing pad to perform the simultaneous fusion and cutting of tissue. An electrosurgical generator is arranged to supply RF energy through the instrument and monitors a phase angle of the supplied RF energy and adjusts or terminates the supplied RF energy based on the monitored phase angle to optimally fuse and dissect the tissue.
Description
BACKGROUND

The present application relates generally to electrosurgical systems and methods and more particularly relates to an electrosurgical fusion/seal and dissection systems.


Electrosurgical devices or instruments have become available that use electrical energy to perform certain surgical tasks. Typically, electrosurgical instruments are surgical instruments such as graspers, scissors, tweezers, blades, needles that include one or more electrodes that are configured to be supplied with electrical energy from an electrosurgical generator. The electrical energy can be used to coagulate, fuse, or cut tissue to which it is applied.


Electrosurgical instruments typically fall within two classifications: monopolar and bipolar. In monopolar instruments, electrical energy is supplied to one or more electrodes on the instrument with high current density while a separate return electrode is electrically coupled to a patient and is often designed to minimize current density. Monopolar electrosurgical instruments can be useful in certain procedures, but can include a risk of certain types of patient injuries such as electrical burns often at least partially attributable to functioning of the return electrode. In bipolar electrosurgical instruments, one or more electrodes is electrically coupled to a source of electrical energy of a first polarity and one or more other electrodes is electrically coupled to a source of electrical energy of a second polarity opposite the first polarity. Bipolar electrosurgical instruments, which operate without separate return electrodes, can deliver electrical signals to a focused tissue area with reduced risks.


Even with the relatively focused surgical effects of bipolar electrosurgical instruments, however, surgical outcomes are often highly dependent on surgeon skill. For example, thermal tissue damage and necrosis can occur in instances where electrical energy is delivered for a relatively long duration or where a relatively high-powered electrical signal is delivered even for a short duration. The rate at which a tissue will achieve the desired coagulation or cutting effect upon the application of electrical energy varies based on the tissue type and can also vary based on pressure applied to the tissue by an electrosurgical device. However, it can be difficult for a surgeon to assess how quickly a mass of combined tissue types grasped in an electrosurgical instrument will be fused a desirable amount.


SUMMARY

In accordance with various embodiments, an electrosurgical laparoscopic fusion/sealer and dissector instrument is provided that is configured to simultaneously fuse and cut tissue. In various embodiments, the electrosurgical device or instrument includes a first jaw and a second jaw opposing the first jaw to grasp tissue between the first and second jaws. The first jaw includes an electrode and the second jaw includes an electrode. The electrodes of the first and second jaws are arranged to fuse and cut tissue between the first and second jaws using radio frequency energy with center portions of the first and second jaws facing each other being devoid of an electrode.


In various embodiments, an electrosurgical instrument comprises a first jaw with a first electrode having a first surface area to contact tissue and a second electrode with a second surface area to contact tissue. The first surface area is the equal to the second surface area. The instrument also includes a second jaw opposing the first jaws and coupled to the first jaw to grasp tissue between the first and second jaws. The second jaw includes a third electrode having a third surface area to contact tissue and a fourth electrode having a fourth surface area to contact tissue. The third surface area is equal to the fourth surface area and the fourth surface area is greater than the first surface area. The first and third electrodes are arranged to fuse tissue between the first and second jaws using radio frequency energy on one side of a longitudinal axis and the second and fourth electrodes are arranged to fuse tissue between the first and second jaws using radio frequency energy on an opposing side of a longitudinal axis.


In accordance with various embodiments, an electrosurgical system for simultaneously fusing and cutting tissue is provided. The system in various embodiments comprises an electrosurgical generator and an electrosurgical fusion/sealer and dissector instrument or device. The generator includes an RF amplifier and a controller. The RF amplifier supplies RF energy through a removably coupled electrosurgical instrument, e.g., an electrosurgical fusion and dissector, configured to fuse and cut tissue with only RF energy. The controller is arranged to monitor a phase angle of the supplied RF energy, the controller signaling the RF amplifier to increase voltage of the supplied RF energy when the monitored phase angle is greater than zero and increasing. In various embodiments, the controller signals the RF amplifier to halt the supplied RF energy when the monitored phase angle decreases.


Many of the attendant features of the present inventions will be more readily appreciated as the same becomes better understood by reference to the foregoing and following description and considered in connection with the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS

The present inventions may be better understood taken in connection with the accompanying drawings in which the reference numerals designate like parts throughout the figures thereof.



FIG. 1 is a perspective view of an electrosurgical system in accordance with various embodiments of the present invention.



FIG. 2 is a perspective view of an electrosurgical generator in accordance with various embodiments of the present invention.



FIG. 3 is a perspective view of an electrosurgical instrument in accordance with various embodiments of the present invention.



FIG. 4 is a perspective view of a distal end of the electrosurgical instrument in accordance with various embodiments of the present invention.



FIG. 5 is a perspective view of a distal end of the electrosurgical instrument in accordance with various embodiments of the present invention.



FIG. 6 is a cross-sectional view of a distal end of an electrosurgical instrument in accordance with various embodiments of the present invention.



FIG. 7 is a cross-sectional view of a distal end of an electrosurgical instrument in accordance with various embodiments of the present invention.



FIG. 8 is a cross-sectional view of a distal end of an electrosurgical instrument in accordance with various embodiments of the present invention.



FIG. 9 is a cross-sectional view of a distal end of an electrosurgical instrument in accordance with various embodiments of the present invention.



FIG. 10 is a cross-sectional view of a distal end of an electrosurgical instrument in accordance with various embodiments of the present invention.



FIG. 11 is a graphical representation of samples of experimental data for a fusion and dissection process with an electrosurgical instrument in accordance with various embodiments of the present invention.



FIG. 12 is a graphical representation of samples of experimental data for a fusion and dissection process with an electrosurgical instrument in accordance with various embodiments of the present invention.



FIG. 13 is a graphical representation of samples of experimental data for a fusion and dissection process with an electrosurgical instrument in accordance with various embodiments of the present invention.



FIG. 14 is a cross-sectional view of a distal end of an electrosurgical instrument in accordance with various embodiments of the present invention.



FIG. 15 is a flow chart illustrating operations of an electrosurgical system in accordance with various embodiments of the present invention.



FIG. 16 is a schematic block diagram of portions of an electrosurgical system in accordance with various embodiments of the present invention.



FIG. 17 is a schematic block diagram of portions of an electrosurgical system in accordance with various embodiments of the present invention.



FIG. 18 is a schematic block diagram of portions of an electrosurgical system in accordance with various embodiments of the present invention.



FIG. 19 is a flow chart illustrating operations of an electrosurgical system in accordance with various embodiments of the present invention.



FIG. 20 is a flow chart illustrating operations of an electrosurgical system in accordance with various embodiments of the present invention.



FIG. 21 is a flow chart illustrating operations of an electrosurgical system in accordance with various embodiments of the present invention.



FIG. 22 is a graphical representation of samples of experimental data for an electrosurgical system in accordance with various embodiments of the present invention.



FIG. 23 is a graphical representation of samples of experimental data for an electrosurgical system in accordance with various embodiments of the present invention.



FIG. 24 is a graphical representation of samples of experimental data for an electrosurgical system in accordance with various embodiments of the present invention.





DETAILED DESCRIPTION

Generally, a bipolar electrosurgical fusion/sealer and dissector instrument, device or tool is provided that is arranged to simultaneously fuse and cut tissue captured between jaws of the instrument. The jaws include particularly positioned, shaped and/or oriented electrodes along with a compressible landing pad to optimally perform the simultaneous fusion and cutting of tissue. The bipolar electrosurgical fusion and dissector can also separately fuse or cut tissue. The cutting of tissue in accordance with various embodiments is notably performed without the use of a mechanical cutting blade, the use of a particular or center cut electrode or the shearing forces or movement of a scissor. The instrument in accordance with various embodiments is provided to be used in laparoscopic surgery having a maximum diameter of 5 mm and thus is insertable through a 5 mm trocar.


Additionally, in general, an electrosurgical system is provided that includes an electrosurgical generator and a removably coupled electrosurgical instrument, e.g., a fusion and dissector, that are configured to optimally fuse and cut tissue. The RF energy is supplied by the electrosurgical generator that is arranged to provide the appropriate RF energy to fuse and cut the tissue. The generator in accordance with various embodiments determines the appropriate RF energy and the appropriate manner to deliver the RF energy for the particular connected electrosurgical instrument, the particular tissue in contact with the instrument and/or a particular surgical procedure. Operationally, RF sealing or fusing of tissue between the jaws is provided to decrease sealing time, output voltage, output power and/or thermal spread. As such, efficiently and consistently delivering power to tissue is provided to heat tissue through a range of temperatures at a particular rate that has been found to be optimal for the tissue affect.


Referring to FIGS. 1-2, an exemplary embodiment of electrosurgical system is illustrated including an electrosurgical generator 10 and a removably connectable electrosurgical instrument 20. The electrosurgical instrument 20 can be electrically coupled to the generator via a cabled connection 30 to a tool or device port 12 on the generator. The electrosurgical instrument 20 may include audio, tactile and/or visual indicators to apprise a user of a particular predetermined status of the instrument such as a start and/or end of a fusion or cut operation. In other embodiments, the electrosurgical instrument 20 can be reusable and/or connectable to another electrosurgical generator for another surgical procedure. In some embodiments, a manual controller such as a hand or foot switch can be connectable to the generator and/or instrument to allow predetermined selective control of the instrument such as to commence a fusion or cut operation.


In accordance with various embodiments, the electrosurgical generator 10 is configured to generate radiofrequency (RF) electrosurgical energy and to receive data or information from the electrosurgical instrument 20 electrically coupled to the generator. The generator 10 in one embodiment outputs RF energy (e.g., 375VA, 150V, 5 A at 350 kHz) and in one embodiment is configured to calculate a phase angle or difference between RF output voltage and RF output current during activation or supply of RF energy. The generator regulates voltage, current and/or power and monitors RF energy output (e.g., voltage, current, power and/or phase). In one embodiment, the generator 10 stops RF energy output under predefine conditions such as when a device switch is de-asserted (e.g., fuse button released), a time value is met, and/or active phase angle and/or change of phase is greater than or equal to a phase and/or change of phase stop value.


The electrosurgical generator 10 comprises two advanced bipolar tool ports 12, a standard bipolar tool port 16, and an electrical power port 14. In other embodiments, electrosurgical units can comprise different numbers of ports. For example, in some embodiments, an electrosurgical generator can comprise more or fewer than two advanced bipolar tool ports, more or fewer than the standard bipolar tool port, and more or fewer than the power port. In one embodiment, the electrosurgical generator comprises only two advanced bipolar tool ports.


In accordance with various embodiments, each advanced bipolar tool port 12 is configured to be coupled to electrosurgical instrument having an attached or integrated memory module. The standard bipolar tool port 16 is configured to receive a non-specialized bipolar electrosurgical tool that differs from the advanced bipolar electrosurgical instrument connectable to the advanced bipolar tool port 12. The electrical power port 14 is configured to receive or be connected to a direct current (DC) accessory device that differs from the non-specialized bipolar electrosurgical tool and the advanced electrosurgical instrument. The electrical power port 14 is configured to supply direct current voltage. For example, in some embodiments, the power port 14 can provide approximately 12 Volts DC. The power port 14 can be configured to power a surgical accessory, such as a respirator, pump, light, or another surgical accessory. Thus, in addition to replacing electrosurgical generator for standard or non-specialized bipolar tools, the electrosurgical generator can also replace a surgical accessory power supply. In some embodiments, replacing presently-existing generators and power supplies with the electrosurgical generator can reduce the amount of storage space required on storage racks cards or shelves in the number of mains power cords required in a surgical workspace.


In one embodiment, connection of a non-specialized bipolar tool into the standard bipolar port will not cause the generator to actively check the tool. However, the generator recognizes a connection so that the information of the non-specialized bipolar tool can be displayed. In accordance with various embodiments, the generator recognizes device connection status for each of the advanced tool ports 12 and authenticates connected devices before accepting RF energy activation requests (e.g., activation of an instrument switch such as a fuse button). The generator in one embodiment reads authenticated data from the connected device and reads electrical control values (such as but not limited to voltage level settings, current level settings, power level settings, active phase angle level settings, RF energy output activation timing limits, instrument short limits, instrument open limits, instrument model/identification, RF energy output line configurations, switch state command configurations and/or combinations thereof) from the authenticated and connected device.


In accordance with various embodiments, the electrosurgical generator 10 can comprise a display 15. The display can be configured to indicate the status of the electrosurgical system including, among other information, the status of the one or more electrosurgical instruments and/or accessories, connectors or connections thereto. In some embodiments, the display can comprise a multi-line display capable of presenting text and graphical information such as for example an LCD panel display, which, in some embodiments can be illuminated via backlight or sidelight. In some embodiments, the display can comprise a multi-color display that can be configured to display information about a particular instrument electrically coupled to the electrosurgical generator and a color that corresponds to a particular surgical procedure (such as, for example cutting operations displayed in yellow text and graphics, fusion or welding operations displayed in purple, and coagulation displayed in blue, bloodless dissection operations can be displayed in yellow and blue).


In some embodiments, the display can be configured to simultaneously indicate status data for a plurality of instruments electrically coupled to the electrosurgical generator and/or be portioned to display status information for each instrument connected to a corresponding tool port. A visual indicator such as a status bar graph can be used to illustrate a proportion of total available electrical energy to be applied to the bipolar electrosurgical instrument when actuated. In various embodiments, an electrosurgical instrument operable to cut, seal, coagulate, or fuse tissue could have three color-coded displays or bar graphs. In some embodiments, a user can toggle the display between presenting status of multiple electrically connected instruments and status of a single electrically connected instrument. In accordance with various embodiments, once an instrument and/or accessory is connected and/or detected a window opens in the user interface display showing the type of instrument connected and status.


The electrosurgical generator in accordance with various embodiments can comprise a user interface such as, for example a plurality of buttons 17. The buttons can allow user interaction with the electrosurgical generator such as, for example, requesting an increase or decrease in the electrical energy supplied to one or more instruments coupled to the electrosurgical generator. In other embodiments, the display 15 can be a touch screen display thus integrating data display and user interface functionalities. In accordance with various embodiments, through the user interface, the surgeon can set a voltage setting by the selection of one to three levels. For example, at level 1, voltage is set to 110V; at level 2, voltage is set to 100V; and at level 3, voltage is set to 90V. Current is set to 5 Amps and power is set to 300 VA for all three levels. In other embodiments, the voltage is preset or defaults to a specific level such as level 2. In other embodiments, like the current and power settings, the voltage setting is not user adjustable to simplify operation of the generator and as such a predetermined default voltage setting is utilized, e.g., voltage is set to 100V.


In one embodiment, the electrosurgical tool or instrument 20 can further comprise of one or more memory modules. In some embodiments, the memory comprises operational data concerning the instrument and/or other instruments. For example, in some embodiments, the operational data may include information regarding electrode configuration/reconfiguration, the instrument uses, operational time, voltage, power, phase and/or current settings, and/or particular operational states, conditions, scripts, processes or procedures. In one embodiment, the generator initiate reads and/or writes to the memory module.


In one embodiment, each advanced bipolar electrosurgical instrument comes with a memory module and/or an integrated circuit that provides instrument authentication, configuration, expiration, and logging. Connection of such instruments into the receptacles or ports initiates an instrument verification and identification process. Instrument authentication in one embodiment is provided via a challenge-response scheme and/or a stored secret key also shared by the generator. Other parameters have hash keys for integrity checks. Usages are logged to the generator and/or to the instrument integrated circuit and/or memory. Errors in one embodiment can result in unlogged usage. In one embodiment, the log record is set in binary and interpreted with offline instruments or via the generator.


In one embodiment, the generator uses time measurement components to monitor an instrument's expiration. Such components utilize polling oscillators or timers or real-time calendar clocks that are configured at boot time. Timer interrupts are handled by the generator and can be used by scripts for timeout events. Logging also utilizes timers or counters to timestamp logged events.


In accordance with various embodiments, the generator provides the capability to read the phase difference between the voltage and current of the RF energy sent through the connected electrosurgical instrument while RF energy is active. While tissue is being fused, phase readings are used to detect different states during the fuse or seal and cut process.


In one embodiment, the generator logs usage details in an internal log that is down loadable. The generator has memory for storage of code and machine performance. The generator has reprogrammable memory that contains instructions for specific instrument performance. The memory for example retains a serial number and instrument use parameters. The generator stores information on the type of instruments connected. Such information includes but is not limited to an instrument identifier, e.g., a serial number of a connected instrument, along with a time stamp, number of uses or duration of use of the connected instrument, power setting of each and changes made to the default setting. The memory in one embodiment holds data for about two months, about 10,000 instrument uses or up to 150 logged activations and is configured to overwrite itself as needed.


The generator in accordance with various embodiments does not monitor or control current, power or impedance. The generator regulates voltage and can adjust voltage. Electrosurgical power delivered is a function of applied voltage, current and tissue impedance. The generator through the regulation of voltage can affect the electrosurgical power being delivered. However, by increasing or decreasing voltage, delivered electrosurgical power does not necessarily increase or decrease. Power reactions are caused by the power interacting with the tissue or the state of the tissue without any control by a generator other than by the generator supplying power.


The generator once it starts to deliver electrosurgical power does so continuously, e.g., every 150 ms, until a fault occurs or a specific phase parameter is reached. In one example, the jaws of the electrosurgical instrument can be opened and thus compression relieved at any time before, during and after the application of electrosurgical power. The generator in one embodiment also does not pause or wait a particular duration or a predetermined time delay to commence termination of the electrosurgical energy.


With reference to FIGS. 3-14, in accordance with various embodiments, an bipolar fusion and dissector electrosurgical instrument 20 is provided. In the illustrated embodiment, the instrument 20 includes an actuator 24 coupled to an elongate rotatable shaft 26. The elongate shaft 26 has a proximal end and a distal end defining a central longitudinal axis therebetween. At the distal end of the shaft 26 are jaws 22 and at the proximal end is the actuator. In one embodiment, the actuator is a pistol-grip like handle. The shaft 26 and jaws 22, in one embodiment, are sized and shaped to fit through a 5 mm diameter trocar cannula or access port.


The actuator 24 includes a movable handle 23 and a stationary handle or housing 28 with the movable handle 23 coupled and movable relative to the stationary housing. In accordance with various embodiments, the movable handle 23 is slidably and pivotally coupled to the stationary housing. In operation, the movable handle 23 is manipulated by a user, e.g., a surgeon to actuate the jaws, for example, selectively opening and closing the jaws. In accordance with various embodiments, the actuator 24 includes a force regulation mechanism that is configured such that in a closed configuration, the jaws 22 delivers a gripping force between a predetermined minimum force and a predetermined maximum force.


As part of the force regulation mechanism, the movable handle 23 is coupled to the stationary handle at two sliding pivot locations to form the force regulation mechanism. The movable handle has a first end including a gripping surface formed thereon and a second end opposite the first end. The movable handle is coupled to a pin adjacent the second end. In some embodiments, the movable handle can be integrally formed with a protrusion extending therefrom defining a pin surface, while in other embodiments, a pin can be press-fit into an aperture in the movable handle. The pin can be contained within slots in the stationary housing, such as a corresponding slot formed in a right and/or left handle frames of the stationary housing. In some embodiments, the slots can be configured to define a desired actuation handle path, such as a curved or angled path, as the actuation handle is moved from the first position corresponding to open jaws to a second position corresponding to closed jaws. The force regulation mechanism includes a biasing member such as a tension spring that biases the pin in a proximal direction. In operation, as a predetermined force is exerted on by movement of the movable handle, a biasing force exerted by the spring is overcome, and the second end of the movable handle can translate generally distally, guided by the pin in the slots.


In accordance with various embodiments, the movable handle is slidably and pivotably coupled to the stationary housing 28 at a location between the first and second ends of the actuation handle. An actuation member such as a pull block is coupled to the actuation handle. When the movable handle is moved proximally, the pull block also moves proximally and longitudinally, closing the jaws 22 thereby clamping any tissue between the jaws. The pull block in accordance with various embodiments is rectangular having open top and bottom faces and a closed proximal end. The movable handle extends through the top and bottom faces of the pull block. An edge of the movable handle bears on the proximal end of the pull block such that movement of the movable handle relative to the stationary housing moves the pull block longitudinally. A distal end of the pull block in one embodiment is coupled to an actuation shaft such as a pull tube, bar, or rod, which can extend longitudinally along the elongate shaft 26. Thus, in operation, movement of the movable handle from the first position to the second position translates the pull block longitudinally within the stationary housing, which correspondingly translates the pull tube generally linearly along the longitudinal axis with respect to the elongate shaft 26. Movement of this pull tube can control relative movement of the jaws 22.


In accordance with various embodiments, the actuator 24 includes a latch mechanism to maintain the movable handle 23 in a second position with respect to the stationary housing 28. In various embodiments, the movable handle comprises a latch arm which engages a matching latch contained within stationary handle for holding the movable handle at a second or closed position. The actuator in various embodiments also comprises a wire harness that includes insulated individual electrical wires or leads contained within a single sheath. The wire harness can exit the stationary housing at a lower surface thereof and form part of the cabled connection. The wires within the harness can provide electrical communication between the instrument and the electrosurgical generator and/or accessories thereof.


In accordance with various embodiments, the actuator includes one or more leads attached to rotational coupling clips configured to allow infinite rotation of the shaft. In various embodiments, a switch is connected to a user manipulated activation button 29 and is activated when the activation button is depressed. In one aspect, once activated, the switch completes a circuit by electrically coupling at least two leads together. As such, an electrical path is then established from an electrosurgical generator to the actuator to supply RF energy to the leads attached to the rotational coupling clips.


In one embodiment, the actuator includes a rotation shaft assembly including a rotation knob 27 which is disposed on an outer cover tube of the elongate shaft 26. The rotation knob allows a surgeon to rotate the shaft of the device while gripping the actuator 24. In accordance with various embodiments, the elongate shaft 26 comprises an actuation tube coupling the jaws 22 with the actuator. In various embodiments, the actuation tube is housed within an outer cover tube. While the actuation tube is illustrated as a generally tubular member that can be nested within the outer cover tube, in other embodiments, a non-tubular actuation member can be used, for example, a shaft, a rigid band, or a link, which, in certain embodiments can be positioned within the outer cover tube.


In accordance with various embodiments, attached to the distal end of the outer cover tube is the rotational shaft assembly comprising two mating hubs and a conductive sleeve. The hubs snap together, engaging with the outer cover tube. In other embodiments, the hubs can be of a monolithic construction and configured to interface with mating features on the outer cover tube. The conductive sleeve can be attached to the proximal portion of the assembled hubs after they are attached to the outer cover tube. When the conductive sleeve is attached to the rear of the assembled hubs, the sleeve traps the exposed end of an isolated wire. In the illustrated embodiment, the isolated wire extends from its entrapment point under the conductive sleeve through a slot in the actuation tube and then inside a protective sleeve. The protective sleeve and isolated wire extend distally inside the actuation tube, towards the jaws. In other embodiments, the isolated wire can be formed integrally with a protective sheath and no separate protective sleeve is present in the actuation tube.


Attached to the distal end of the elongate shaft are jaws 22 that comprise a first jaw 70 and a second jaw 80. In one embodiment, a jaw pivot pin pivotally couples the first and second jaws and allows the first jaw to be movable and pivot relative to the second jaw. In various embodiments, one jaw is fixed with respect to the elongate shaft such that the opposing jaw pivots with respect to the fixed jaw between an open and a closed position. In other embodiments, both jaws can be pivotally coupled to the elongate shaft such that both jaws can pivot with respect to each other.


The jaw geometry provides for specific pressure profiles and specific current densities in specific locations to produce the required fusion/seal and dissection effect. Operationally, the temperature required to achieve sealing and division is minimized while the cross linking of proteins within the vascular structure are maximized thereby maximizing the efficacy of the fuse/seal and division of tissue.


In accordance with various embodiments, in order to monitor the temperature of the biological reaction, phase angle and/or the rate of change of the phase angle is monitored. It has been found that the phase angle provides indicators of the temperature of the biological reaction and an indication that the division of the tissue has occurred. In accordance with various embodiments, the device uses bipolar RF energy for electrosurgery for cutting and fusing of tissue between the jaws when opened or closed and/or in contact with the lower jaw when the jaws are open or closed. In one embodiment, temperature of the tissue during the seal and/or division cycle is monitored.


The advanced bipolar electrosurgical device in accordance with various embodiments uses bipolar RF energy for both the sealing or fusing and the division or cutting of tissue. As such, the device maintains cellular structure of tissue adjacent to the area of division while applying the energy required for the division of tissue. Other RF dissection devices use localized arcing or a spark gap to vaporize tissue and achieve dissection. This may be acceptable for straight tissue dissection because the surrounding area is not also intended to be sealed or fused, but is unlike the fusion and dissector devices and systems in accordance with various embodiments of the present invention.


The advanced bipolar electrosurgical device in accordance with various embodiments also accounts for the high heat associated with the vaporization of tissue or tissue dissection. As such, the device in various embodiments uses temperature control to minimize the energy required to achieve tissue division. By minimizing the energy required, the temperature during the reaction is lower and the cellular structure is less likely to be disrupted due to high energy output.


Maintaining the cellular structure of the operating tissue is needed when simultaneously fusing and dissecting or dividing because it is necessary for sealing to occur adjacent to the area of division. The addition of open cut and seal mode also reduces the number of devices or the exchange of devices used in performance of a surgical procedure as such or all such functionality of such individual devices are provided in the single advanced bipolar laparoscopic device.


In various embodiments, the electrosurgical instrument comprises movable jaws able to capture tissue therebetween. In one embodiment, the jaws include one upper jaw that closes onto a static lower jaw. In accordance with various embodiments, the upper jaw includes a rigid upper jaw member 41, an upper conductive pad 42, a rigid insulating pad 43, a wire 44, and a compressible landing pad 45 which are all bound together using an insert molding process and thus is provided as a single structure or assembly as shown in the FIG. 6.


The rigid upper jaw member and the upper conductive pad are both active electrodes which have opposite polarities. The compressible landing pad provides a surface with a specific spring rate to ensure that contact and pressure occurs between the landing pad and the length of the lower jaw. The upper conductive pad 42 is electrically isolated from the rigid upper jaw member 41 by the landing pad 45 and the insulating pad 43. In various embodiments, the upper jaw is made of stainless steel and is more rigid than the landing pad 45. In various embodiments, the landing pad 45 is made of silicone and is more compliant than the upper jaw member 41 or conductive pad 42. In various embodiments, the insulating pad is made of a non-conductive material and is as rigid as or more rigid than the upper jaw member 41 or the conductive pad 42. In various embodiments, the upper jaw member 41 and the conductive pad are made of the same material.


The upper jaw member 41 and the conductive pad have a lower outer surface arranged to be in contact with tissue. The lower surfaces are angled or sloped and mirror images of each other with such positioning or orientation facilitating focused current densities and securement of tissue. The compressible landing pad 45 has a lower surface arranged to be in contact with tissue and/or the lower jaw. The landing pad in the illustrated embodiment is flat and non-parallel relative to the sloped lower surfaces of upper jaw member and the conductive pad 42. The positioning or orientation of the lower surface of the landing pad assists in focusing current densities, securing of tissue and facilitating electrically dissecting of tissue. The spring rate of the landing pad in various embodiments is predetermined to provide optimal pressure or force to cause or facilitate the electrical division of tissue.


The lower jaw comprises a rigid lower jaw member 52, a lower conductive pad 53, a cut electrode 55, two rigid insulators 54, 56, as well as two wires, one to the conductive pad and one to the cut electrode, all of which is bound together using an insert molding process and thus are provided as a single structure or assembly as shown in FIG. 7 in accordance with various embodiments of the present invention. The rigid lower jaw member 52, the lower conductive pad 53, and the cut electrode 55 are all or act as active electrodes. The lower conductive pad 53 and the cut electrode 55 have the same polarity and are electrically isolated by the two rigid insulators 54 and 56 from the rigid lower jaw member which has the opposite polarity.


The lower jaw member 52 and the conductive pad 53 have an upper outer surface arranged to be in contact with tissue. The upper surfaces are angled or sloped and mirror images of each other with such positioning or orientation facilitating focused current densities and securement of tissue. In various embodiments, the lower jaw is made of stainless steel and is as rigid as or more rigid than the conductive pad 53. In various embodiments, the rigid insulators 54, 56 are made of a non-conductive material and are as rigid as or more rigid than the lower jaw member 52 or the conductive pad 53. In various embodiments, the lower jaw member 52 and the conductive pad 53 are made of the same material.


The overall jaw configuration in accordance with various embodiments is shown in cross-section in FIG. 8 and demonstrates the interaction of the geometries (e.g., shape, dimension, material and any combination thereof for optimal fusion and dissection) between the upper jaw and the lower jaw. In operation, the conductive pads 42, 53 are of the same polarity. The upper and lower jaw members 41, 51, 52 are the same polarity, but the opposite polarity of the conductive pads 42, 53. In one embodiment, the cut electrode 55 is only active during an open cut and fuse operation and is the opposite polarity of the lower jaw member 52. As illustrated, the landing pad 45 interferes and compresses onto the lower jaw member 52 and conductive pad 53 upon closure of the jaws. Tissue (not shown) also captured between the lower jaw and the upper jaw is compressed between the landing pad 45 and the lower jaw member 52 and the conductive pad 53.


The polarity of each electrode is set to create the appropriate RF energy and heating due to electrical current passing therebetween. As shown in FIG. 9, the direction of current flow allows for heating between the conductive pads and the jaw members, as well as creating heating from side to side on the lower jaw configuration, as exemplified by arrows 101. The side to side heating on the lower jaw configuration is provided for the division of tissue, as exemplified by arrow 102. In order to divide the tissue down the middle of the jaw, the tissue is heated to reach a temperature between 60° C. and 100° C. to denature the collagen present in the tissue. Once the collagen has been denatured, it enters into a gelatin like state.


As the tissue is gelatinous or in a gelatin like state, the spring rate and the interference of the silicone landing pad causes mechanical separation of the tissue as exemplified in FIG. 10 and arrow 103. In various embodiments, the spring rate is predetermined to optimize the separation of the tissue by the interference with the pad and the lower jaw such that the landing pad compresses a predetermined distance or amount in conformance with the tissue there between and with minimal or no effects to the adjacent tissue. Therefore, the configuration of the electrodes allow for simultaneous heating of the seal area (the area between the conductive pads and the jaw members) and the cut area (the side to side current region on the lower jaw). The denaturing of the collagen is also the mechanism used to create a tissue seal or fuse. Sealing utilizes the same temperature (60° C. to 100° C.) as cutting, but the jaw seal spacing between the conductive pads and the jaw members creates a form or mold for the seal to re-cross-link once the RF application ceases. It is noted that reaching high temperatures rapidly can cause the cellular structure to rupture due to the rapid heating of intercellular moisture. Therefore, a gradual increase of temperature and a longer dwell time in the appropriate temperature range allows for more thorough denaturing of the collagen.


In various embodiments, in order to achieve the appropriate temperature of the tissue to cause the associated tissue effect, e.g., a gradual increase and/or longer dwell time, the phase angle of the tissue and/or the rate of change of the phase angle are monitored. FIGS. 11-13 provide a graphical representation of exemplary seal and division cycles in accordance with various embodiments. Also, as illustrated, phase 111g is shown relative to other tissue readings or indicators such as voltage 111a, power 111b, impedance 111c, energy 111d, temperature 111e and current 111f. Additionally, although shown in FIGS. 11-13, in various embodiments, the generator is configured to not measure or calculate one or more of the indicators or readings, e.g., temperature or energy, to reduce operational and power costs and consumptions and/or the number of parts of the generator. The additional information or readings are generally provided or shown for context purposes.


As shown in FIGS. 11-13, the temperature of the tissue 111e between the jaws increases from the initiation of RF energy to a point of the highest phase angle. At this point of the highest phase angle (or the point of inflection of the rate of change of phase angle) 155 the temperature plateaus 150 momentarily (˜0.75 seconds), then continues higher 152, even though voltage decreases.


Due to the behavior of the temperature profile, it is noted that the momentary plateau in temperature may be attributed to the change in state of the water or moisture present in the tissue. When the water begins to boil, the temperature does not increase until the liquid water has been turned to water vapor. The determination of the temperature 111e as such can be based off the phase angle 111g. The temperature prior to the maximum phase angle is associated with a steady heating to 100° C. The plateau in temperature is associated with a sudden decrease in the phase angle which can be associated with 100° C. and two-state water. Because liquid water is highly conductive and water vapor is not, this transition in phase may be another indicator of the water's state. Once the temperature continues to increase past 100° C. (152) and past a second point of phase angle inflection 160, it can be noted that the majority of the water has been turned to water vapor.


Another point of interest that can be seen in the RF output is the sudden spike 170 in power 111b and current 111f during the boiling of water portion of the RF application as shown for example in FIG. 13. The spike can be attributed to the division of the tissue during the sealing or fusing process. This increase in power and current can be due to tissue being no longer present under the insulated portion of the jaws, e.g., the landing pad. At this point, the jaw closes more, and the energy transfer is only through the seal surfaces.


Since the temperature required to denature the collagen begins at 60° C., the energy application is optimized to maximize the time prior to 100° C. This provides for a complete and thorough denaturing of the collagen. As such, all sealing should be completed prior to the spike 170 in power and current such that sealing is completed prior to division.


In accordance with various embodiments, the electrosurgical instrument also has the ability to cut tissue using RF energy and in one embodiment only with the jaws in a fully open position, only utilizing the lower jaw, without cooperation of the upper jaw or tissue not captured between the upper and lower jaws but in contact with the lower jaw. FIG. 14 shows the direction of current flow, arrow 140, from the cut electrode 55 to the rigid lower jaw member 52.


To achieve tissue cutting, a high voltage potential is created between the cut electrode 55 and the lower jaw member 52. This provides for the vaporization of tissue due to the heat created by local arcing around the cut electrode. As high temperature is encountered, the insulating material used to isolate the cut electrode in one embodiment withstands or operates well at high temperatures. Also, with the high voltage potential, the insulator in one embodiment has a high dielectric strength. The voltage potential is greater than 400 V-peak in order to achieve sufficient arcing. The actual potential however is directly related to the spacing between the cut electrode and the lower jaw member.


Arc suppression is another concern and as such quick rectification of RF waveform distortion due to arcing and/or limiting power output to prevent the degradation of the materials used in the construction of the jaw are provided. If an arc is allowed to persist for more than 100 micro seconds, there is an increased risk of device degradation. Also, due to the extreme heat associated with the localized arcing, RF energy application in accordance with various embodiments includes a predetermined duty cycle or a waveform with a high crest factor. It has been found that the crest factor associated with a sinusoidal waveform does not allow for a constant output without causing degradation to the device. Manipulation of the duty cycle or crest factor brings the average output power down over the entire activation of the device.


The electrosurgical instrument in accordance with various embodiments also fuses tissue using RF energy and in one embodiment only with the jaws in a fully open position, only utilizing the lower jaw, without cooperation of the upper jaw or tissue not captured between the upper and lower jaws but in contact with the lower jaw. FIG. 14 exemplarily illustrates a direction of current flow from the cut electrode 55 to the rigid lower jaw member 52.


In accordance with various embodiments, to cause tissue coagulation, a low voltage potential is maintained between the cut electrode 55 and the lower jaw member 52. The voltage potential is set to be lower than 100 V-peak in order to prevent localized arcing, but the actual potential is directly related to the spacing between the cut electrode and the lower jaw member. Tissue coagulation is caused by heat generated by the RF current between the two electrodes.


In one embodiment, the isolated wire 44 is routed to electrically couple the first jaw to the wiring harness in the actuator. The isolated wire extends from the distal end of the protective sleeve which is housed at the proximal end of the second jaw and extends into the first jaw. The first jaw can have a slot positioned to receive the isolated wire. The isolated wire then extends through a hole in the first jaw and drops into a slot in a nonconductive portion. The isolated wire then extends to the distal end of the nonconductive portion and drops through to the conductive pad.


In some embodiments, electrode geometry of or on the conductive pads of the jaws ensures that the sealing area completely encloses the distal portion of the cutting path. In accordance with various embodiments, the dimensions of the jaw surfaces are such that it is appropriately proportioned with regards to the optimal pressure applied to the tissue between the jaws for the potential force the force mechanism can create. Its surface area is also electrically significant with regards to the surface area contacting the tissue. This proportion of the surface area and the thickness of the tissue have been optimized with respect to its relationship to the electrical relative properties of the tissue.


In one embodiment, as illustrated in FIG. 15, an electrosurgical process such as a tissue fusion and/or cut process starts with depressing a switch on the tool (151), which starts an initial measurement sequence. With engagement of a switch on the tool, the generator takes initial measurements on the tissue (opens, shorts, etc.) (152) and based on the initial measurements initiates or does not initiate the supply of RF energy (153). In accordance with various embodiments, the generator measures tool and/or tissue impedance and/or resistance, and/or if a phase angle is within an acceptable range. In one embodiment, the generator performs a passive measurement of tissue between the electrodes of an electrosurgical tool connected to the generator utilizing RF energy with a low energy range (e.g., a voltage about 1-10 Volts) that does not cause a physiological effect. In various embodiments, the generator uses the initial impedance measurement to determine if the tool is shorted, faulty, open and the like. Based on a positive result of the initial check, the generator for example switches—in a supply of RF energy from the generator to the electrosurgical tool and ultimately to the tissue (154). After RF power is turned on and is being supplied continuously by the generator, the generator monitors the phase angle or difference and/or change of phase angle between current and voltage of the supplied RF energy (155).


At or upon a predefined or predetermined point, condition or threshold (156), the supply of RF energy is terminated (157). In this case, an acoustical and/or visual signal is provided indicating that the tissue is fused (or that an error has occurred (e.g., shorting of the electrodes) and/or an unexpected condition has occurred (e.g., permissible although unexpected switch release)). In accordance with various embodiments, the predefined point, condition or threshold and/or initialization checks are determined based on a tool algorithm or script provided for a connected electrosurgical tool, procedure or preference. In accordance with various embodiments, the product of measured tissue permittivity and conductivity or an initial phase shift is utilized to determine the end point for a connected tool.


Referring now to FIG. 16, in one embodiment, the electrosurgical generator 10 is connected to AC main input and a power supply 141 converts the AC voltage from the AC main input to DC voltages for powering various circuitry of the generator. The power supply also supplies DC voltage to an RF amplifier 142 that generates RF energy. In one embodiment, the RF amplifier 142 converts 100 VDC from the power supply to a sinusoidal waveform with a frequency of 350 kHz which is delivered through a connected electrosurgical instrument. RF sense circuitry 143 measures/calculates voltage, current, power and phase at the output of the generator in which RF energy is supplied to a connected electrosurgical instrument 20. The measured/calculated information is supplied to a controller 144.


In one embodiment, the RF sense analyzes the measured AC voltage and current from the RF amplifier and generates DC signals for control signals including voltage, current, power, and phase that are sent to the controller for further processing. In one embodiment, RF sense 143 measures the output voltage and current and calculates the root means square (RMS) of the voltage and current, apparent power of the RF output energy and the phase angle between the voltage and current of the RF energy being supplied through a connected electrosurgical instrument. In particular, the voltage and current of the output RF energy are processed by analog circuitry of the RF sense to generate real and imaginary components of both voltage and current. These signals are processed by an field-programmable gate array (FPGA) to give different measurements relating to voltage and current, including the RMS measurements of the AC signals, phase shift between voltage and current, and power. Accordingly, in one embodiment, the output voltage and current are measured in analog, converted to digital, processed by an FPGA to calculate RMS voltage and current, apparent power and phase angle between voltage and current, and then are converted back to analog for the controller.


For each device port there are a pair of signals for voltage and a pair of signals for current that originate from the RF amplifier 142. In one embodiment, the generator has two redundant RF sense circuits 143a, 143b that measures voltage and current for each device at different locations on the RF amplifier. The first RF Sense circuit senses current by sense resistors delivered through a connected electrosurgical instrument on either device port 1 or device port 2, and the voltage measured across return to output on either device port 1 or device port 2. The second RF Sense circuit senses current by sense resistors, returned from a connected electrosurgical instrument on either device port 1 or device port 2, and the voltage 146a, 146b measured across output to return on either device port 1 or device port 2. The voltage input signals are high voltage sinusoidal waveforms at 350 kHz that are attenuated and AC coupled by a voltage divider and an inverting filter to remove DC bias on the signals. An inverting filter is used as the voltage and current inputs are 180 degrees out of phase as they are measured at opposite polarities. For each voltage input signal, two separate inverted and non-inverted voltage sense signals are generated. In one embodiment, a differential voltage measurement is made between the current input signals to generate two separate pairs of inverted and non-inverted current sense signals. The current input signals represent voltage across a shunt resistor on the RF Amplifier in which this voltage is proportional to the current flowing through the shunt resistor. The current input signals are low voltage sinusoidal waveforms at 350 kHz that are amplified using a non-inverting filter to remove DC bias on the signals. The RF Sense generates a signal that is analogous to multiplying each voltage and current signal by predetermined reference signals. As such, the RF Sense provides the non-inverted voltage and current sense signals when the waveform is positive, the inverted voltage and current sense signals when the waveform is negative, and a ground signal when the waveform is zero.


The RF sense in accordance with various embodiments receives four reference synchronization signals supplied by the controller via the RF amplifier. The synchronization signals are 350 kHz pulse signals with the same duty cycle but with differing phase shifts and in one embodiment are 90 degrees phase shifted from each other. Two of the synchronization signals are used to generate the in-phase waveforms to generate the real component of the input waveforms and the two other synchronization signals are used to generate the quadrature waveforms to generate the imaginary components of the input waveforms. These signals are processed further to generate control signals to a plurality of switches. The outputs of the switches are tied together to generate a single output. In one embodiment, the control signals to the switches determine which input signal passes through to the single output. In accordance with various embodiments, a first combination allows non-inverted voltage and current sense signals to pass through which represents or is analogous to multiplying these sense signals by a positive pulse. A second combination allows the inverted voltage and current sense signals to pass through which represents or is analogous to multiplying these sense signals by a negative pulse. A third combination allows the ground signal to pass through generating a zero voltage output which represents or is analogous to multiplying the sense signals by zero. Each output is supplied to a low pass filter that generates a DC voltage corresponding to the real or imaginary component of the sensed signals. These signals are supplied to ADCs which sends a digital signal to the FPGA.


In one embodiment, Controller 144 controls the RF amplifier 142 to affect the output RF energy. For example, Controller utilizes the information provided by the RF sense 143 to determine if RF energy should be outputted and when to terminate the output of RF energy. In one embodiment, the controller compares a predetermined phase threshold based on a particular tissue in contact with the connected electrosurgical device 20 to determine when to terminate the output of RF energy. In various embodiments, the controller performs a fusion process described in greater detail below and in some embodiments the controller receives the instructions and settings or script data to perform the fusion process from data transmitted from the electrosurgical instrument.


In accordance with various embodiments as shown in FIG. 17, the generator has six major sub-systems or modules of circuitry that include System Power or Power Supply 145, Controller 144, Front Panel Interface 146, Advanced Bipolar Device Interface 147, RF Amplifier 142 and RF Sense 143. In accordance with various embodiments, one or more of the circuitry may be combined or incorporated with other circuitry. The power supply 145 is configured to provide DC voltages to all the other circuitry or sub-systems along with control signals to control the power supply outputs. The power supply receives AC power input that is 90-264 VAC, 47-63 Hz and in one embodiment the power supply has a switch, integrated or separate, that is configured to connect or disconnect the AC power input from the generator. The controller through the Front Panel Interface (FPI) and Advanced Bipolar Device Interface (ABDI) supports the user interface 121 and instrument connections for electrosurgical devices 1 and 2 connected to the electrosurgical generator.


The RF Amplifier 142 generates high power RF energy to be passed through a connected electrosurgical instrument and in one example, an electrosurgical instrument for fusing of tissue. The RF Amplifier in accordance with various embodiments is configured to convert a 100 VDC power source to a high power sinusoidal waveform with a frequency of 350 kHz which is delivered through the ABDI 147 and eventually the connected electrosurgical device. The RF Sense 143 interprets the measured AC voltage and current from the RF amplifier 42 and generates DC control signals, including voltage, current, power, and phase, that is interpreted by Controller 144.


The generator has a plurality of specialized connection receptacles, in the illustrated embodiment device port 1 and device port 2, that are used only for connecting to advanced bipolar devices, such as an advanced bipolar electrosurgical instrument. The specialized receptacles each include an array spring-loaded probes or pogo pins. The generator in various embodiments includes a circuit to detect the presence of an advanced bipolar device prior to energizing any active output terminals at the receptacles.


The Front Panel Interface (FPI) 146 is configured to drive a display, device signals from the controllers and LED backlights for front panel buttons. The FPI is also configured to provide power isolation through regulators and provide functionality for the front panel switches/buttons. In one embodiment, the ABDI 147 is used as a pass-through connection which provides a connection to the devices through the FPI. The FPI also provides connection between Controller 144 and a connected electrosurgical device through the ABDI. The device interface in one embodiment is electrically isolated from the rest of the FPI. The interface in various embodiments includes lines that read and write to an ferromagnetic random access memory (FRAM) on an advanced bipolar device, read a trigger switch and/or read a signal that indicates a device is connected. In one embodiment, a device memory circuit is provided that utilizes the controller's serial peripheral interface (SPI) to read and write the FRAM of the advanced bipolar device. In one embodiment, the FRAM is replaced with a microcontroller and the interface includes an interrupt line so all information passed through a digital interface between the electrosurgical device and the generator. FPI provides isolation for SPI signals to and from advanced bipolar device through ABDI. In one embodiment, the SPI interface is shared between two advanced bipolar devices with port pins being used as chip selects.


In accordance with various embodiments, the generator includes a SPI communication bus that allows the controller to have bi-directional communication with complex programmable logic devices (CPLDs) and the RF Sense FPGAs. In various embodiments, the FPI provides SPI interface between the controller and connected devices through an ABDI connector to communicate with the FRAM on the advanced bipolar devices. FPI also provides electrical isolation for low voltage signals from between controller and the ABDI. The device interface on the ABDI is configured to transmit RF energy to the connected device along with SPI communication. In one embodiment, the ABDI connects a signal from a device that indicates it is connected.


The FPI-ABDI interface provides power to the devices that connect to the generator, SPI communication between controller and the devices, device switch signals from the devices to the controller, and device connected signals from the devices to the controller. ABDI provides the RF energy to each connected advanced bipolar device through a separate pogo pin array. The FPI provides signal, low voltage power and high voltage RF power from the FPI and RF Amplifier to the connected device through the ABDI connector via the pogo pin array.


In accordance with various embodiments, an operations engine enables the generator to be configurable to accommodate different operational scenarios including but not limited to different and numerous electrosurgical tools, surgical procedures and preferences. The operations engine receives and interprets data from an external source to specifically configure operation of the generator based on the received data.


The operations engine receives configuration data from a database script file that is read from a memory device on a device plug. The script defines the state logic used by the generator. Based on the state determined and measurements made by the generator, the script can define or set output levels as well as shutoff criteria. The script in one embodiment includes trigger events that include indications of short condition for example when a measured phase is greater than 70 degrees or an open condition for example when a measured phase is less than −50 degrees.


In one embodiment, the operations engine provides system states and user states. System states are predefined or predetermined states that control or manage specific predefined or predetermined operations of the generator, such as successfully applying RF energy or indicating an error. System states in one embodiment are a pre-defined set of configuration that the system can be in (e.g., idle vs. energized) and whose functions are hard-coded into the electrosurgical generator. For example, a RF Done state is a system state that indicates that an RF energy cycle has been completed without errors. User states provide a framework through which customized or specialized operations and values can be established by direction from an external source for a particular tool, procedure and/or preference.


In one embodiment, the script sets forth the system states and their exit conditions, e.g., expiration times or pointers or directions to another state and where the user states begin. For each user state, operation parameters for the specific state can be defined such as power, voltage, and current settings or are carried over from a previous state. In one embodiment, the user states may provide device, operator or procedural specific states and in one embodiment, the user states may be provided for testing or diagnostics specific states.


Referring to FIG. 18, the generator 10 receives script information from the electrosurgical device or instrument 20 when the device is connected. The generator uses this script information to define a number of states and the order of execution of the states.


The script source file or script information 180 written by the device script author and not resident on the instrument or the generator 10 is text or user readable. The script information is compiled using a script complier 185 to generate a device script database or binary file (SDB) 101. The script binary file is transferred by a device key programmer 187 to a memory module that is connectable or incorporated into the electrosurgical instrument 20 via a device key 182. As the electrosurgical instrument is connected to the electrosurgical generator, the generator authenticates the script binary file and/or the instrument (188). The generator validates the script binary file (189) and if validated the operations engine utilizes the script initiated by the actuation by the connected instrument (190). Script source file in one embodiment is a text file containing a device script that is specific for a specific electrosurgical instrument, generator and/or surgical procedure. The script source file for a device in one embodiment includes information containing parameters and a script (states, functions, events) for the electrosurgical generator and/or electrosurgical instrument. After successful validation, the script compiler assembles data into a binary format that defines a state machine for use by the electrosurgical generator. Script compiler as shown in FIG. 18 in one embodiment is separate from the electrosurgical generator and is responsible for reading in text from the script source file and validating its contents.


When the memory module is inserted into the generator, the generator downloads a binary file that is stored in a ferromagnetic random access memory (FRAM) or microcontroller disposed within the module. The binary includes logic for implementing the treatment algorithms or processes in accordance with various embodiments. The generator in various embodiments includes firmware/software, hardware or combinations thereof responsible for processing the binary to authentic the connected instrument and to execute the binary for performing the treatment algorithm. In this manner, the generator is configured to operate only with authenticated, compatible hand tools.


In one embodiment, instrument scripts or script database represent an instrument process for a specific or given instrument. The instrument scripts are stored on memory connected to or integrated with an instrument, the controller or a combination thereof. The event handler responds to specific events, such as a switch activation/de-activation, instrument positions or exceeding measurement thresholds. The operations engine based on the detected event if appropriate for a given event provides output to the connected instrument. In one embodiment, an event is a discrete change, as in a switch is asserted or de-asserted.


Script state is a block or set of script functions or operation conditions and script events or indicators. Script functions are configurable instructions for controlling the generator and/or the instruments. Script operators are logical and comparison operations performed during a script event evaluation. Script parameters are configuration data used by all states and events of a script and in one embodiment are declared in their own dedicated section of the script file. Script events are a discrete change in an electrosurgical generator measurement. When a Script Event occurs, for example, a sequence of script functions is executed.


In accordance with various embodiments, phase angle between voltage and current and/or the change or phase angle rate is utilized to maximize the amount of time the tissue is in a predetermined temperature range. In one embodiment, the predetermined temperature range is between 60 degrees C. to 100 degrees C. In one embodiment, low voltage is utilized to minimize temperature effects while accelerating sealing or fusing time.


In accordance with various embodiments, tissue is grasped between jaws of the bipolar electrosurgical device. The bipolar electrosurgical device removably connected to an electrosurgical generator is supplied RF energy that upon command is supplied to the tissue. The supplied RF energy has a predetermined voltage range that heats the tissue at a predetermined rate. In one embodiment, the predetermined voltage range is between 20 Vrms to 50 Vrms. During the application of RF energy, the phase angle between output voltage and current are monitored to identify phase increases or decreases. Initially, phase angle is monitored to determine a change in phase angle or rate from increasing to decreasing. It is contemplated that once this point of inflection has occurred, it is determined that water in the jaws of the device has reached 100 degrees C. and the temperature to cause the required tissue affect has been exceeded. A shutoff point is then determined to terminate the supply of RF energy.


Exemplary RF energy control process for the electrosurgical generator and associated electrosurgical tool for fusing tissue in accordance with various embodiments are shown in FIGS. 19-21. In various embodiments, as illustrated in FIG. 19, RF energy is supplied by the generator through the connected electrosurgical tool (251). The generator monitors at least the phase and/or change/rate of phase of the supplied RF energy (252). If a phase/phase change is greater than zero or trending positive (253), voltage is increased (254). The generator continues to monitor at least the phase and/or change/rate of phase of the supplied RF energy (255). If the phase/phase change continues to increase (256), the generator continues to monitor the phase and/or change of phase. If the phase/phase change decreases (257), the process is done or termination procedures are initiated and/or RF energy supplied by the generator is stopped (258).


In one embodiment, prior to the start of the process, impedance is measured to determine a short or open condition through a low voltage measurement signal delivered to a connected electrosurgical tool. In one embodiment, passive impedance is measured to determine if the tissue grasped is within the operating range of the electrosurgical tool (2-200Ω). If the initial impedance check is passed, RF energy is supplied to the electrosurgical tool. After which impedance/resistance is not measured or ignored.


Initially, initial parameters are set to prepare for sealing of tissue grasped between the jaws. In one embodiment, voltage and current settings are set to a specific setting. In one embodiment, voltage of the RF energy is applied in a ramping fashion starting from 30% of a global setting or user selected level (e.g., 27.5-88V for level 1, 25.0-80V for level 2 and 22.5V-72V for level 3). The voltage DAC is set to 30% of the voltage setting which on level 2 (medium) is 25.5 Vrms. The phase is monitored to determine a phase angle above zero degrees and to heat the tissue and water between the jaws of the electrosurgical device at a predetermined slow rate.


Referring now to FIGS. 20-21, in various embodiments, RF energy is supplied by the generator through the connected electrosurgical tool (251). The generator monitors at least the phase and/or change/rate of phase of the supplied RF energy (252). If a phase/phase change is greater than zero or trending positive (253), voltage is increased (254). In various embodiments, voltage is increased at a predetermined rate, for example, 50% over 5 seconds, which is 42.5 Vrms on level 2 (medium) after the phase has increased to be greater than zero degrees. The ramping continues until a predetermined condition is met. In one embodiment, the ramping continues as the monitored phase angle increases to above five degrees. This ensures that phase is increasing as expected based on heating of the tissue.


In a next subsequent state (265), if the monitored phase angle increases above a predetermined phase value, e.g., 5 degrees, phase continues to be monitored for an increasing state or condition. This is contemplated that such an increasing condition is an indication that the temperature of the tissue and water between the jaws is increasing but less than 100 degrees C. However, the monitored phase indicating a decreasing state or condition provides a different indication. It is contemplated that such an indication is that the temperature of the tissue and water between the jaws has reached at least 100 degrees C. and/or the desired tissue affect has been completed, e.g., sealing and/or cutting of the tissue.


In one or more subsequent states, the monitored phase angle is checked for an increasing or decreasing condition. In accordance with various embodiments, various incremental or periodic checks are performed along with various incremental or periodic updates to various predetermined thresholds or indications to determine an increasing phase angle or rates of change condition or a decreasing phase angle or rates of change condition.


When one or more of the subsequent states determines that the phase angle, rate or trend of the phase angle is decreasing rather than increasing, the indication is that the desired tissue affect has been completed, e.g., sealing and/or cutting of the tissue. As such, it is contemplated that in such an indication the temperature of the tissue and water between the jaws has reached at least 100 degrees C.


At such a state or in a subsequent state, voltage ramping or increasing of the output RF energy is ramped down or decreased. As such, the rapid boiling of water is reduced or prevented and temperature is held steady or constant until a predetermined condition is reached. In one embodiment, the predetermined condition is the phase angle dropping to at least 5 degrees.


In accordance with various embodiments, in a next subsequent state (266), if the monitored phase angle increases above a predetermined phase value, e.g., 10 degrees, phase continues to be monitored for an increasing state or condition. If however the monitored phase angle instead indicates a decreasing state, e.g., decreases below a predetermined phase value, e.g., five degrees (268) or a predetermined time limit has been reached, voltage increase is stopped (280). Subsequently, if the monitored phase angle continues to indicate a decreasing state, e.g., decreases below a predetermined phase value, e.g., five degrees (268) or if a predetermined time limit has been reached, RF energy is stopped and the process ends (281).


If the monitored phase angle indicates an increasing state, e.g., in a next subsequent state (267), if the monitored phase angle increases above a predetermined phase value, e.g., 12.5 degrees, phase continues to be monitored for a continued increasing state or condition. If the monitored phase angle instead now indicates a decreasing state, e.g., decreases below a predetermined phase value, e.g., 7.5 degrees (269) or a predetermined time limit has been reached, voltage increase is stopped (280). Subsequently, if the monitored phase angle continues to indicate a decreasing state, e.g., decreases below a predetermined phase value, e.g., five degrees (268) or if a predetermined time limit has been reached, RF energy is stopped and the process ends (281).


In a next subsequent state (270), if the monitored phase angle indicates an increasing state, e.g., increases above a predetermined phase value, e.g., 15 degrees, voltage increase is stopped (271) and phase continues to be monitored for an increasing state or condition. If however the monitored phase angle instead indicates a decreasing state, e.g., decreases below a predetermined phase value, e.g., ten degrees (277) or a predetermined time limit has been reached, voltage increase is stopped (280). Subsequently, if the monitored phase angle continues to indicate a decreasing state, e.g., decreases below a predetermined phase value, e.g., five degrees (282) or if a predetermined time limit has been reached, RF energy is stopped and the process ends (281). In a next subsequent state (272), if the monitored phase angle indicates an increasing state, e.g., increases above a predetermined phase value, e.g., 20 degrees, phase continues to be monitored for an increasing state or condition. If the monitored phase angle instead indicates an decreasing state, e.g., decreases below a predetermined phase value, e.g., ten degrees (277) or a predetermined time limit has been reached, phase continues to be monitored for a decreasing state or condition. Subsequently, if the monitored phase angle decreases below a predetermined phase value, e.g., five degrees (282) or if a predetermined time limit has been reached, RF energy is stopped and the process ends (281).


In a next subsequent state (273), if the monitored phase angle continues to indicate an increasing state, e.g., increases above a predetermined phase value, e.g., 25 degrees, phase continues to be monitored for an increasing state or condition. If the monitored phase angle decreases instead below a predetermined phase value, e.g., fifteen degrees (278) or a predetermined time limit has been reached, phase continues to be monitored for a decreasing state or condition. Subsequently, if the monitored phase angle decreases below a predetermined phase value, e.g., five degrees (282) or if a predetermined time limit has been reached, RF energy is stopped and the process ends (281). In a next subsequent state (274), if the monitored phase angle increases above a predetermined phase value, e.g., 30 degrees, phase continues to be monitored for an increasing state or condition. If the monitored phase angle instead decreases below a predetermined phase value, e.g., fifteen degrees (278) or a predetermined time limit has been reached, phase continues to be monitored for a decreasing state or condition. Subsequently, if the monitored phase angle decreases below a predetermined phase value, e.g., five degrees (285) or if a predetermined time limit has been reached, RF energy is stopped and the process ends (281).


In a next subsequent state (275), if the monitored phase angle increases above a predetermined phase value, e.g., 35 degrees, phase continues to be monitored for an increasing state or condition. However, if the monitored phase angle instead decreases below a predetermined phase value, e.g., fifteen degrees (278) or a predetermined time limit has been reached, phase continues to be monitored for a decreasing state or condition. Subsequently, if the monitored phase angle decreases below five degrees (282) or if a predetermined time limit has been reached, RF energy is stopped and the process ends (281). In a next subsequent state (276), if the monitored phase angle increases above a predetermined phase value, e.g., 40 degrees, phase is monitored for a decreasing condition and if the monitored phase angle decreases below a predetermined phase value, e.g., fifteen degrees (278) or a predetermined time limit has been reached, phase continues to be monitored for a decreasing state or condition. Subsequently, if the monitored phase angle decreases below a predetermined phase value, e.g., five degrees (282) or if a predetermined time limit has been reached, RF energy is stopped and the process ends (281). It is contemplated and noted that, for the exemplary and operational seal/fuse and cut/dissection process or system provided above and throughout the application, the frequency of incremental checks and/or the indications of increasing or decreasing states, e.g., predetermined angles or rates of change, can vary to provide different and various levels and granularity of regulation or control as desired or required based on the specific electrosurgical instrument, generator, tissue and/or surgical procedure.



FIGS. 22-24 are graphical representations of exemplary vessel sealing/fusing utilizing systems and processes in accordance with various embodiments of the present invention. As shown, the success rate 223 of providing a tissue seal above 3× systolic burst pressure are high and time 223 for sealing of vessels up to 4 mm in size was small, e.g., less than 2 seconds. The times for sealing vessels between 4-7 mm was also reduced, e.g., less than 5 seconds. The time for the phase angle to decrease from the maximum to a predetermined phase value, e.g., 5 degrees, is longer than those up to 4 mm. Such changes or reduction in sealing time while also providing successful vessel seals, e.g., withstanding above 3× systolic burst pressure, in accordance with various embodiments is refined by identifying and/or triggering at the point of inflection of the derivate of the phase trend and incorporated into incremental checks, state indicators or thresholds. In various embodiments, the point of inflection of the derivate of the phase trend is identified at the point where the phase trend changes from an increasing state to a decreasing state.


As shown in FIG. 23, the vessel was 6.62 mm in diameter and was successfully sealed, e.g., having a burst pressure of 12.7 psi. Additionally, as shown, the phase angle 230g increases as RF energy is applied. The rate of the increase is not rapid but rather sufficiently slow as well as the temperature 230d of the tissue. The point of inflection 231, e.g., the point at which phase changes from increasing to decreasing occurs approximately 1.5 seconds before RF energy is stopped. As shown in FIG. 24, the vessel was 1.89 mm in diameter and was successfully sealed, e.g., having a burst pressure of 13 psi. The overall trend of phase angle 240g and temperature 240d is similar as with the previous vessel seal, although the time scale shown in FIG. 24 is approximately ¼ of that of FIG. 23. Also, as illustrated, phase 230g, 240g are shown relative to other tissue readings or indicators such as voltage 230a, 240a; power 230b, 240b; impedance 230e, 240e; energy 230c, 240c; temperature 230d, 240d; and current 230f, 240f. Additionally, although shown in FIGS. 23-24, in various embodiments, the generator is configured to not measure or calculate one or more of the indicators or readings, e.g., temperature or energy, to reduce operational and power costs and consumptions and the number of parts for the generator. The additional information or readings are generally provided or shown for context purposes.


It is noted that the impedance of the tissue is near its minimum for the entire seal cycle. As such, this provides a low voltage and high current and thus consistent power delivery throughout the seal cycle. Efficient or consistent power delivery reduces thermal spread. In accordance with various embodiments, the time for sealing can be decreased, reduction in voltage output to below 50 Vrms and/or reduction of power output to below 50 Watts. To avoid false readings, in accordance with various embodiments, the electrosurgical generator does not measure resistance or impedance of the tissue during the supply of RF energy to the tissue.


In accordance with various embodiments, an electrosurgical system is provided that decreases thermal spread, provides lower output levels and efficient power delivery for sealing vessels or tissue in contact with a bipolar electrosurgical instrument through the controlled and efficient supply of RF energy.


As described throughout the application, the electrosurgical generator ultimately supplies RF energy to a connected electrosurgical instrument. The electrosurgical generator ensures that the supplied RF energy does not exceed specified parameters and detects faults or error conditions. In various embodiments, an electrosurgical instrument provides the commands or logic used to appropriately apply RF energy for a surgical procedure. An electrosurgical instrument for example includes memory having commands and parameters that dictate the operation of the instrument in conjunction with the electrosurgical generator. For example, in a simple case, the generator can supply the RF energy but the connected instrument decides how much or how long energy is applied. The generator however does not allow the supply of RF energy to exceed a set threshold even if directed to by the connected instrument thereby providing a check or assurance against a faulty instrument command.


Turning now to some of the operational aspects of the electrosurgical tool or instrument described herein in accordance with various embodiments, once a vessel or tissue bundle has been identified for fusing, dissecting or both, the first and second jaws are placed around the tissue. The movable handle 23 is squeezed moving the movable handle proximally with respect to the stationary housing 28. As the movable handle moves proximally the first jaw pivots towards the second jaw effectively clamping the tissue. Radio frequency energy is applied to the tissue by depressing the activation button on the stationary handle. Once the tissue has been fused, dissected or both, the movable handle is re-opened.


Alternatively or additionally, with the jaws in a fully open position or in an intermediate position between a fully open position and the engaged position, radio frequency energy can applied to the tissue in contact with a lower surface or portion of the lower jaw by depressing the activation button or a separate activation button to fuse and/or dissect tissue.


As described generally above and described in further detail below, various electrosurgical instruments, tools or devices can be used in the electrosurgical systems described herein. For example, electrosurgical graspers, scissors, tweezers, probes, needles, and other instruments incorporating one, some, or all of the aspects discussed herein can provide various advantages in an electrosurgical system. Various electrosurgical instruments and generator embodiments and combinations thereof are discussed throughout the application. It is contemplated that one, some, or all of the features discussed generally throughout the application can be included in any of the embodiments of the instruments, generators and combinations thereof discussed herein. For example, it can be desirable that each of the instruments described include a memory for interaction with the generator as previously described and vice versa. However, in other embodiments, the instruments and/or generators described can be configured to interact with a standard bipolar radio frequency power source without interaction of an instrument memory. Further, although various embodiments may be described in terms of modules and/or blocks to facilitate description, such modules and/or blocks may be implemented by one or more hardware components, e.g., processors, Digital Signal Processors (DSPs), Programmable Logic Devices (PLDs), Application Specific Integrated Circuits (ASICs), circuits, registers and/or software components, e.g., programs, subroutines, logic and/or combinations of hardware and software components. Likewise, such software components may be interchanged with hardware components or a combination thereof and vice versa.


Further examples of the electrosurgical unit, instruments and connections there between and operations and/or functionalities thereof are described in U.S. patent application Ser. No. 12/416,668, filed Apr. 1, 2009, entitled “Electrosurgical System”; Ser. No. 12/416,751, filed Apr. 1, 2009, entitled “Electrosurgical System”; Ser. No. 12/416,695, filed Apr. 1, 2009, entitled “Electrosurgical System”; Ser. No. 12/416,765, filed Apr. 1, 2009, entitled “Electrosurgical System”; and Ser. No. 12/416,128, filed Mar. 31, 2009, entitled “Electrosurgical System”; the entire disclosures of which are hereby incorporated by reference as if set in full herein. Certain aspects of these electrosurgical generators, tools and systems are discussed herein, and additional details and examples with respect to various embodiments are described in U.S. Provisional Application No. 61/994,215, filed May 16, 2014, entitled “Electrosurgical Fusion Device”; 61/944,185, filed May 16, 2014, “Electrosurgical Generator with Synchronous Detector”; 61/994,415, filed May 16, 2014, “Electrosurgical System”; and 61/944,192, filed May 16, 2014, entitled “Electrosurgical Generator”, the entire disclosures of which are hereby incorporated by reference as if set in full herein.


The above description is provided to enable any person skilled in the art to make and use the surgical instruments and perform the methods described herein and sets forth the best modes contemplated by the inventors of carrying out their inventions. Various modifications, however, will remain apparent to those skilled in the art. It is contemplated that these modifications are within the scope of the present disclosure. Additionally, different embodiments or aspects of such embodiments may be shown in various figures and described throughout the specification. However, it should be noted that although shown or described separately each embodiment and aspects thereof may be combined with one or more of the other embodiments and aspects thereof unless expressly stated otherwise. It is merely for easing readability of the specification that each combination is not expressly set forth. Also, embodiments of the present invention should be considered in all respects as illustrative and not restrictive.

Claims
  • 1. An electrosurgical system comprising: an electrosurgical generator arranged to supply radio frequency (RF) energy through an electrosurgical instrument removably connectable thereto, the electrosurgical generator comprising a controller arranged to periodically monitor a phase angle of the supplied RF energy and configured to signal an RF amplifier to increase voltage of the supplied RF energy when the monitored phase angle is greater than zero and increasing; andthe electrosurgical instrument comprising:a first jaw;a second jaw opposing the first jaw, the first and second jaws pivotably arranged to grasp tissue between the first and second jaws;a first electrode disposed on the first jaw; anda second electrode disposed on the second jaw, the first and second electrodes of the first and second jaws being arranged to transmit radio frequency energy between the first and second electrodes to fuse and cut the tissue between the first and second jaws with a center portion of the first jaw comprising a compressible insulated landing pad extending from the first jaw and towards a center portion of the second jaw.
  • 2. The electrosurgical system of claim 1 wherein the controller continues to signal the RF amplifier to increase voltage of the RF energy when the monitored phase angle continues to exceed a predetermined threshold angle and the RF amplifier increases voltage of the supplied RF energy at a predetermined constant rate.
  • 3. The electrosurgical system of claim 2 wherein the controller is configured to signal the RF amplifier to halt the supplied RF energy when the monitored phase angle decreases.
  • 4. The electrosurgical system of claim 3 wherein the controller periodically monitors a rate of change of the phase angle of the supplied RF energy and the controller signals the RF amplifier to halt the supplied RF energy when the rate of change of the phase angle falls below a predetermined threshold rate.
  • 5. The electrosurgical system of claim 1 wherein the RF amplifier increases voltage of the supplied RF energy at a predetermined constant rate and the controller signals the RF amplifier to halt the voltage increase of the supplied RF energy when the monitored phase angle exceeds a predetermined threshold angle while the RF amplifier continues to supply RF energy.
  • 6. The electrosurgical system of claim 1 wherein the first jaw further comprises a third electrode and the second jaw further comprises a fourth electrode and a fifth electrode, the fifth electrode extending away from the first jaw and the second jaw.
  • 7. The electrosurgical system of claim 6 wherein the first and second electrodes are arranged to fuse tissue between the first and second jaws using radio frequency energy on one side of a longitudinal axis and the third and fourth electrodes are arranged to fuse the tissue between the first and second jaws using radio frequency energy on an opposing side of the longitudinal axis.
  • 8. The electrosurgical system of claim 7 wherein the second and fourth electrodes are arranged to heat the tissue between the first and second jaws through radio frequency energy being conducted between the second and fourth electrodes and wherein the compressible landing pad divides tissue down a middle of the first and second jaws relative to the longitudinal axis.
  • 9. The electrosurgical system of claim 8 wherein the fifth electrode is arranged to cut the tissue outside the second jaw through radio frequency energy being conducted between the fifth electrode and the second and fourth electrodes.
  • 10. The electrosurgical system of claim 9 wherein the first and fourth electrodes are arranged to have a same first polarity as each other and the second and third electrodes are arranged to have a same second polarity as each other and different to the first polarity of the first and fourth electrodes to fuse and cut the tissue between the first and second jaws.
  • 11. The electrosurgical system of claim 10 wherein the compressible landing pad on the first jaw is disposed directly above the fifth electrode and a flat portion of the second electrode and a flat portion of the fourth electrode.
  • 12. The electrosurgical system of claim 11 wherein the compressible landing pad is flat relative to an angled surface of the first electrode and an angled surface of the third electrode.
  • 13. The electrosurgical system of claim 1 wherein the first electrode is angled, sloping towards the second jaw and away from the compressible landing pad, the first electrode having one end near the compressible landing pad and another end at a periphery of the first jaw.
  • 14. The electrosurgical system of claim 13 wherein the compressible landing pad deforms when the first jaw and the second jaw are in a proximate position.
  • 15. The electrosurgical system of claim 13 wherein the second electrode protrudes up towards the first jaw to a first inner flat portion of the second electrode and the fourth electrode protrudes up towards the first jaw to a second inner flat portion of the fourth electrode adjacent to the first inner flat portion of the second electrode.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of International Application No. PCT/US2015/033546, filed Jun. 1, 2015, which claims the benefit of U.S. Provisional Application No. 62/005,009, filed May 30, 2014, and U.S. Provisional Application No. 62/004,980, filed May 30, 2014, the entire disclosures of which are incorporated by reference as if set forth in full herein.

US Referenced Citations (1148)
Number Name Date Kind
371664 Brannan et al. Oct 1887 A
702472 Pignolet Jun 1902 A
728883 Downes May 1903 A
1586645 Bierman Jun 1926 A
1935289 Evans Nov 1933 A
2002594 Wappler et al. May 1935 A
2031682 Wappler et al. Feb 1936 A
2113246 Wappler Apr 1938 A
2176479 Willis Oct 1939 A
2305156 Grubel Dec 1942 A
2632661 Cristofv Mar 1953 A
2827056 Degelman Mar 1958 A
3085566 Tolles Apr 1963 A
3459187 Pallotta Aug 1969 A
3494363 Jackson Feb 1970 A
3588710 Masters Jun 1971 A
3651811 Hildebrandt et al. Mar 1972 A
3685518 Beuerle et al. Aug 1972 A
3780416 Rider Dec 1973 A
3826263 Cage et al. Jul 1974 A
3911766 Fridolph et al. Oct 1975 A
3920021 Hiltebrandt Nov 1975 A
3938527 Rioux et al. Feb 1976 A
3963030 Newton Jun 1976 A
3970088 Morrison Jul 1976 A
3980085 Ikuno Sep 1976 A
3987795 Morrison Oct 1976 A
4030501 Archibald Jun 1977 A
4041952 Morrison, Jr. et al. Aug 1977 A
4043342 Morrison, Jr. Aug 1977 A
4060088 Morrison, Jr. et al. Nov 1977 A
4074718 Morrison, Jr. Feb 1978 A
4089336 Cage et al. May 1978 A
4092986 Schneiderman Jun 1978 A
4094320 Newton et al. Jun 1978 A
4114623 Meinke et al. Sep 1978 A
4126137 Archibald Nov 1978 A
4154240 Ikuno et al. May 1979 A
4171700 Farin Oct 1979 A
4181131 Ogui Jan 1980 A
4188927 Harris Feb 1980 A
4196734 Harris Apr 1980 A
4198957 Cage et al. Apr 1980 A
4198960 Utsugi Apr 1980 A
4200104 Harris Apr 1980 A
4231372 Newton Nov 1980 A
4237887 Gonser Dec 1980 A
4244371 Farin Jan 1981 A
4325374 Komiya Apr 1982 A
4331149 Gonser May 1982 A
4338940 Ikuno Jul 1982 A
4352156 Gyugyi Sep 1982 A
4370980 Lottick Feb 1983 A
4416276 Newton et al. Nov 1983 A
4416277 Newton et al. Nov 1983 A
4427014 Bel et al. Jan 1984 A
4429694 McGreevy Feb 1984 A
4463759 Garito et al. Aug 1984 A
4487489 Takamatsu Dec 1984 A
4514619 Kugelman Apr 1985 A
4522206 Whipple et al. Jun 1985 A
4552143 Lottick Nov 1985 A
4569131 Faulk et al. Feb 1986 A
4569345 Manes Feb 1986 A
4590934 Malis et al. May 1986 A
4599553 Brennen et al. Jul 1986 A
4630218 Hurley Dec 1986 A
4632109 Paterson Dec 1986 A
4644950 Valli Feb 1987 A
4651280 Chang et al. Mar 1987 A
4655216 Tischer Apr 1987 A
4657018 Hakky Apr 1987 A
4658815 Farin et al. Apr 1987 A
4658819 Harris et al. Apr 1987 A
4658820 Klicek Apr 1987 A
4674498 Stasz Jun 1987 A
4685459 Koch et al. Aug 1987 A
4699146 Sieverding Oct 1987 A
4712545 Honkanen Dec 1987 A
4716897 Noguchi et al. Jan 1988 A
4727874 Bowers et al. Mar 1988 A
4739759 Rexroth et al. Apr 1988 A
4741334 Irnich May 1988 A
4752864 Clappier Jun 1988 A
4754757 Feucht Jul 1988 A
4788977 Farin et al. Dec 1988 A
4802476 Noerenberg et al. Feb 1989 A
4818954 Flachenecker et al. Apr 1989 A
4827927 Newton May 1989 A
4848335 Manes Jul 1989 A
4850353 Stasz et al. Jul 1989 A
4860745 Farin et al. Aug 1989 A
4862889 Feucht Sep 1989 A
4862890 Stasz et al. Sep 1989 A
4872456 Hasson Oct 1989 A
4887612 Esser et al. Dec 1989 A
4889722 Sheffield et al. Dec 1989 A
4903696 Stasz et al. Feb 1990 A
4905691 Rydell Mar 1990 A
4922903 Welch et al. May 1990 A
4936281 Stasz Jun 1990 A
4937254 Sheffield et al. Jun 1990 A
4938761 Ensslin Jul 1990 A
4942313 Kinzel Jul 1990 A
4958539 Stasz et al. Sep 1990 A
4969885 Farin Nov 1990 A
4976711 Parins et al. Dec 1990 A
5007908 Rydell Apr 1991 A
5013312 Parins et al. May 1991 A
5015227 Broadwin et al. May 1991 A
5016521 Haka May 1991 A
5026370 Lottick Jun 1991 A
5026371 Rydell et al. Jun 1991 A
5035696 Rydell Jul 1991 A
5038109 Goble et al. Aug 1991 A
5047026 Rydell Sep 1991 A
5047027 Rydell Sep 1991 A
5052402 Bencini et al. Oct 1991 A
5057107 Parins et al. Oct 1991 A
5061269 Muller Oct 1991 A
5062031 Flachenecker et al. Oct 1991 A
5071419 Rydell et al. Dec 1991 A
5078717 Parins et al. Jan 1992 A
5083565 Parins Jan 1992 A
5085659 Rydell Feb 1992 A
5087257 Farin et al. Feb 1992 A
5098431 Rydell Mar 1992 A
5116332 Lottick May 1992 A
5122137 Lennox Jun 1992 A
5125928 Parins et al. Jun 1992 A
5127412 Cosmetto et al. Jul 1992 A
5151102 Kamiyama et al. Sep 1992 A
5158561 Rydell et al. Oct 1992 A
5160343 Brancel et al. Nov 1992 A
5167658 Ensslin Dec 1992 A
5171255 Rydell Dec 1992 A
5171311 Rydell Dec 1992 A
5190517 Zieve et al. Mar 1993 A
5190541 Abele et al. Mar 1993 A
5192280 Parins Mar 1993 A
5197963 Parins Mar 1993 A
5197964 Parins Mar 1993 A
5201732 Parins et al. Apr 1993 A
5217457 Delahuerga et al. Jun 1993 A
5217458 Parins Jun 1993 A
5234427 Ohtomo et al. Aug 1993 A
5244462 Delahuerga et al. Sep 1993 A
5246440 Van Noord Sep 1993 A
5250047 Rydell Oct 1993 A
5250056 Hasson Oct 1993 A
5254126 Filipi et al. Oct 1993 A
5256149 Banik et al. Oct 1993 A
5258006 Rydell et al. Nov 1993 A
5267997 Farin et al. Dec 1993 A
5269780 Roos Dec 1993 A
5273524 Fox et al. Dec 1993 A
5281216 Klicek Jan 1994 A
5282799 Rydell Feb 1994 A
5286255 Weber Feb 1994 A
5290286 Parins Mar 1994 A
5300070 Gentelia et al. Apr 1994 A
5304190 Reckelhoff et al. Apr 1994 A
5312329 Beaty et al. May 1994 A
5314424 Nicholas May 1994 A
5318563 Malis et al. Jun 1994 A
5322055 Davison et al. Jun 1994 A
5324289 Eggers Jun 1994 A
5330471 Eggers Jul 1994 A
5334183 Wuchinich Aug 1994 A
5338317 Hasson et al. Aug 1994 A
5341807 Nardella Aug 1994 A
5341815 Cofone et al. Aug 1994 A
5342359 Rydell Aug 1994 A
5342381 Tidemand Aug 1994 A
5352222 Rydell Oct 1994 A
5352223 McBrayer et al. Oct 1994 A
5354313 Boebel Oct 1994 A
5356408 Rydell Oct 1994 A
5370645 Klicek et al. Dec 1994 A
5372124 Takayama et al. Dec 1994 A
5372596 Klicek et al. Dec 1994 A
5374277 Hassler Dec 1994 A
5382247 Cimino et al. Jan 1995 A
5383880 Hooven Jan 1995 A
5383922 Zipes et al. Jan 1995 A
5387196 Green et al. Feb 1995 A
5387197 Smith et al. Feb 1995 A
5389104 Hahnen et al. Feb 1995 A
5389849 Asano et al. Feb 1995 A
5391166 Eggers Feb 1995 A
5392917 Alpern et al. Feb 1995 A
5400267 Denen et al. Mar 1995 A
5403312 Yates et al. Apr 1995 A
5403342 Tovey et al. Apr 1995 A
5405344 Willaimson et al. Apr 1995 A
5409498 Braddock et al. Apr 1995 A
5417687 Nardella et al. May 1995 A
5422567 Matsunaga Jun 1995 A
5423808 Edwards et al. Jun 1995 A
5423810 Goble et al. Jun 1995 A
5431638 Hennig et al. Jul 1995 A
5431649 Mulier et al. Jul 1995 A
5431674 Basile et al. Jul 1995 A
5432459 Thompson et al. Jul 1995 A
5436566 Thompson et al. Jul 1995 A
5437664 Cohen et al. Aug 1995 A
5438302 Goble Aug 1995 A
5443463 Stern Aug 1995 A
5445142 Hassler, Jr. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5447513 Davison et al. Sep 1995 A
5449355 Rhum et al. Sep 1995 A
5456684 Schmidt et al. Oct 1995 A
5458598 Feinberg et al. Oct 1995 A
5460182 Goodman et al. Oct 1995 A
5462546 Rydell Oct 1995 A
5464144 Guy et al. Nov 1995 A
5472439 Hurd Dec 1995 A
5472442 Klicek Dec 1995 A
5472443 Cordis et al. Dec 1995 A
5472451 Freitas et al. Dec 1995 A
5474057 Makower et al. Dec 1995 A
5476479 Green et al. Dec 1995 A
5478351 Meade et al. Dec 1995 A
5486185 Freitas et al. Jan 1996 A
5496312 Klicek Mar 1996 A
5496317 Goble et al. Mar 1996 A
5499992 Meade et al. Mar 1996 A
5499998 Meade et al. Mar 1996 A
5503320 Webster et al. Apr 1996 A
5507773 Huitema et al. Apr 1996 A
5509916 Taylor Apr 1996 A
5514129 Smith May 1996 A
5514134 Rydell et al. May 1996 A
5518163 Hooven May 1996 A
5518164 Hooven May 1996 A
5527313 Scott et al. Jun 1996 A
5527330 Tovey Jun 1996 A
5531744 Nardella et al. Jul 1996 A
5540681 Strul et al. Jul 1996 A
5540684 Hassler, Jr. Jul 1996 A
5540685 Parins et al. Jul 1996 A
5541376 Ladtkow et al. Jul 1996 A
5551945 Yabe et al. Sep 1996 A
5558429 Cain Sep 1996 A
5558671 Yates Sep 1996 A
5562699 Heimberger et al. Oct 1996 A
5562700 Huitema et al. Oct 1996 A
5571100 Goble et al. Nov 1996 A
5571121 Heifetz Nov 1996 A
5573424 Poppe Nov 1996 A
5573533 Strul Nov 1996 A
5573534 Stone Nov 1996 A
5573535 Viklund Nov 1996 A
5575789 Bell et al. Nov 1996 A
5575805 Li Nov 1996 A
5584830 Ladd et al. Dec 1996 A
5599344 Paterson Feb 1997 A
5599350 Schulze et al. Feb 1997 A
5603711 Parins et al. Feb 1997 A
D378611 Croley Mar 1997 S
5607391 Klinger et al. Mar 1997 A
5609151 Mulier et al. Mar 1997 A
5609560 Ichikawa et al. Mar 1997 A
5609573 Sandock Mar 1997 A
5611709 McAnulty Mar 1997 A
5613966 Makower et al. Mar 1997 A
5620415 Lucey et al. Apr 1997 A
5620447 Smith et al. Apr 1997 A
5624452 Yates Apr 1997 A
5626575 Crenner May 1997 A
5626607 Malecki et al. May 1997 A
5626608 Cuny et al. May 1997 A
5627584 Nishikori et al. May 1997 A
5633578 Eggers et al. May 1997 A
5645540 Henniges et al. Jul 1997 A
5647869 Goble et al. Jul 1997 A
5651780 Jackson et al. Jul 1997 A
5658279 Nardella et al. Aug 1997 A
5658281 Heard Aug 1997 A
5665100 Yoon Sep 1997 A
5665105 Furnish et al. Sep 1997 A
5667517 Hooven Sep 1997 A
5669907 Platt, Jr. et al. Sep 1997 A
5674184 Hassler, Jr. Oct 1997 A
5674220 Fox et al. Oct 1997 A
5683349 Makower et al. Nov 1997 A
5688270 Yates et al. Nov 1997 A
5693045 Eggers Dec 1997 A
5693051 Schulze et al. Dec 1997 A
5695494 Becker Dec 1997 A
5697281 Eggers et al. Dec 1997 A
5697909 Eggers et al. Dec 1997 A
5700261 Brinkerhoff Dec 1997 A
5702386 Stern et al. Dec 1997 A
5702387 Arts et al. Dec 1997 A
5702390 Austin et al. Dec 1997 A
5707369 Vaitekunas et al. Jan 1998 A
5709680 Yates et al. Jan 1998 A
5713128 Schrenk et al. Feb 1998 A
5713895 Lontine et al. Feb 1998 A
5713896 Nardella Feb 1998 A
5720742 Quinn et al. Feb 1998 A
5720744 Eggleston et al. Feb 1998 A
5720745 Farin et al. Feb 1998 A
5722975 Edwards et al. Mar 1998 A
5725524 Mulier et al. Mar 1998 A
5735848 Yates et al. Apr 1998 A
5735849 Baden et al. Apr 1998 A
5743456 Jones et al. Apr 1998 A
5743906 Parins et al. Apr 1998 A
5746210 Benaron et al. May 1998 A
5746740 Nicholas May 1998 A
5746759 Meade et al. May 1998 A
5752519 Benaron et al. May 1998 A
5755717 Yates et al. May 1998 A
5759185 Grinberg Jun 1998 A
5762609 Benaron et al. Jun 1998 A
5766167 Eggers et al. Jun 1998 A
5769791 Benaron et al. Jun 1998 A
5769841 Odell et al. Jun 1998 A
5772597 Goldberger et al. Jun 1998 A
5772659 Becker et al. Jun 1998 A
5772660 Young et al. Jun 1998 A
5776092 Farin et al. Jul 1998 A
5776129 Mersch Jul 1998 A
5776130 Buysse et al. Jul 1998 A
5776155 Beaupre et al. Jul 1998 A
5782397 Koukline Jul 1998 A
5785658 Benaron et al. Jul 1998 A
5792139 Chambers et al. Aug 1998 A
5792178 Welch et al. Aug 1998 A
5797906 Rhum et al. Aug 1998 A
5797938 Paraschac et al. Aug 1998 A
5797941 Schulze et al. Aug 1998 A
5800449 Wales Sep 1998 A
5807261 Benaron et al. Sep 1998 A
5807393 Williamson, IV et al. Sep 1998 A
5807395 Mulier et al. Sep 1998 A
5810806 Ritchart et al. Sep 1998 A
5810811 Yates et al. Sep 1998 A
5810859 DiMatteo et al. Sep 1998 A
5817091 Nardella et al. Oct 1998 A
5817093 Williamson, IV et al. Oct 1998 A
5817119 Klieman et al. Oct 1998 A
5827271 Buysse et al. Oct 1998 A
5827279 Hughett et al. Oct 1998 A
5827299 Thomason et al. Oct 1998 A
5830231 Geiges, Jr. Nov 1998 A
5833690 Yates et al. Nov 1998 A
5836942 Netherly et al. Nov 1998 A
5836943 Miller, III Nov 1998 A
5846194 Wasson et al. Dec 1998 A
5849020 Long et al. Dec 1998 A
5853412 Mayenberger Dec 1998 A
5860975 Goble et al. Jan 1999 A
5873873 Smith et al. Feb 1999 A
5876398 Mulier et al. Mar 1999 A
5876401 Schulze et al. Mar 1999 A
5885277 Korth Mar 1999 A
5891095 Eggers et al. Apr 1999 A
5891141 Rydell Apr 1999 A
5891142 Eggers et al. Apr 1999 A
5893835 Witt et al. Apr 1999 A
5893873 Rader et al. Apr 1999 A
5897490 Fox et al. Apr 1999 A
5897523 Wright et al. Apr 1999 A
5897553 Mulier et al. Apr 1999 A
5897569 Kellogg et al. Apr 1999 A
5902264 Toso et al. May 1999 A
5902301 Olig May 1999 A
5904709 Arndt et al. May 1999 A
5906613 Mulier et al. May 1999 A
5908402 Blythe Jun 1999 A
5908420 Parins et al. Jun 1999 A
5910152 Bays Jun 1999 A
5928137 Green Jul 1999 A
5928255 Meade et al. Jul 1999 A
5928256 Riza Jul 1999 A
5931836 Hatta et al. Aug 1999 A
5935126 Riza Aug 1999 A
5938633 Beaupre Aug 1999 A
5944715 Goble et al. Aug 1999 A
5944718 Austin et al. Aug 1999 A
5944737 Tsonton et al. Aug 1999 A
5947284 Foster Sep 1999 A
5947984 Whipple Sep 1999 A
5951552 Long et al. Sep 1999 A
5954736 Bishop et al. Sep 1999 A
5954746 Holthaus et al. Sep 1999 A
5957943 Vaitekunas Sep 1999 A
5961514 Long et al. Oct 1999 A
5968062 Thomas et al. Oct 1999 A
5968074 Prestel Oct 1999 A
5976077 Wittens et al. Nov 1999 A
5976128 Schilling et al. Nov 1999 A
5980510 Tsonton et al. Nov 1999 A
5980516 Mulier et al. Nov 1999 A
5984921 Long et al. Nov 1999 A
5987346 Benaron et al. Nov 1999 A
5993380 Yabe et al. Nov 1999 A
5993447 Blewett et al. Nov 1999 A
5995875 Blewett et al. Nov 1999 A
5997533 Kuhns Dec 1999 A
6003517 Sheffield et al. Dec 1999 A
6004319 Goble et al. Dec 1999 A
6004335 Vaitekunas et al. Dec 1999 A
6010499 Cobb Jan 2000 A
6010516 Hulka Jan 2000 A
6013076 Goble et al. Jan 2000 A
6015406 Goble et al. Jan 2000 A
6016809 Mulier et al. Jan 2000 A
D420741 Croley Feb 2000 S
6024741 Williamson, IV et al. Feb 2000 A
6024744 Kese et al. Feb 2000 A
6027501 Goble et al. Feb 2000 A
6027522 Palmer Feb 2000 A
6030384 Nezhat Feb 2000 A
6030402 Thompson et al. Feb 2000 A
6033399 Gines Mar 2000 A
6033404 Melzer et al. Mar 2000 A
6036657 Milliman et al. Mar 2000 A
6039733 Buysse et al. Mar 2000 A
6039734 Goble Mar 2000 A
6039736 Platt, Jr. Mar 2000 A
6050996 Schmaltz et al. Apr 2000 A
6051010 DiMatteo et al. Apr 2000 A
6053172 Hovda et al. Apr 2000 A
6053914 Eggers et al. Apr 2000 A
6056746 Goble et al. May 2000 A
6063050 Manna et al. May 2000 A
6063075 Mihori May 2000 A
6063081 Mulier et al. May 2000 A
6063086 Benecke et al. May 2000 A
6066139 Ryan et al. May 2000 A
6068627 Orszulak et al. May 2000 A
6068647 Witt et al. May 2000 A
6070444 Lontine et al. Jun 2000 A
6074386 Goble et al. Jun 2000 A
RE36795 Rydell Jul 2000 E
6083191 Rose Jul 2000 A
6086586 Hooven Jul 2000 A
6090106 Goble et al. Jul 2000 A
6090120 Wright et al. Jul 2000 A
6092722 Heinrichs et al. Jul 2000 A
6093186 Goble Jul 2000 A
6096037 Mulier et al. Aug 2000 A
6102909 Chen et al. Aug 2000 A
6106521 Blewett et al. Aug 2000 A
6109268 Thapliyal et al. Aug 2000 A
6110171 Rydell Aug 2000 A
6113591 Whayne et al. Sep 2000 A
6113594 Savage Sep 2000 A
6113596 Hooven et al. Sep 2000 A
6113598 Baker Sep 2000 A
6117152 Huitema Sep 2000 A
6120501 Long et al. Sep 2000 A
H1904 Yates Oct 2000 H
6132429 Baker Oct 2000 A
6135998 Palanker Oct 2000 A
6139519 Blythe Oct 2000 A
6139547 Lontine et al. Oct 2000 A
6142992 Cheng et al. Nov 2000 A
6152923 Ryan Nov 2000 A
6159146 El Gazayerli Dec 2000 A
6162235 Vaitekunas Dec 2000 A
6165175 Wampler et al. Dec 2000 A
6168605 Measamer et al. Jan 2001 B1
6171304 Netherly et al. Jan 2001 B1
6174308 Goble et al. Jan 2001 B1
6174309 Wrublewski et al. Jan 2001 B1
6179834 Buysse et al. Jan 2001 B1
6186147 Cobb Feb 2001 B1
6187003 Buysse et al. Feb 2001 B1
6187026 Devlin et al. Feb 2001 B1
6190383 Schmaltz et al. Feb 2001 B1
6190385 Tom et al. Feb 2001 B1
6190386 Rydell Feb 2001 B1
6193129 Bittner et al. Feb 2001 B1
6193653 Evans et al. Feb 2001 B1
6193713 Geistert et al. Feb 2001 B1
6197026 Farin et al. Mar 2001 B1
6203541 Keppel Mar 2001 B1
6206823 Kolata et al. Mar 2001 B1
6206844 Reichel et al. Mar 2001 B1
6206875 Long et al. Mar 2001 B1
6206877 Kese et al. Mar 2001 B1
6210403 Klicek Apr 2001 B1
6210405 Goble et al. Apr 2001 B1
6214003 Morgan et al. Apr 2001 B1
6214023 Whipple et al. Apr 2001 B1
6228023 Zaslavsky et al. May 2001 B1
6228055 Foerster et al. May 2001 B1
6228080 Gines May 2001 B1
6228081 Goble May 2001 B1
6228083 Lands et al. May 2001 B1
6234178 Goble et al. May 2001 B1
6237604 Burnside et al. May 2001 B1
6238366 Savage et al. May 2001 B1
6238392 Long May 2001 B1
6238393 Mulier et al. May 2001 B1
6242741 Miller et al. Jun 2001 B1
6246912 Sluijter et al. Jun 2001 B1
6251106 Becker et al. Jun 2001 B1
6251110 Wampler Jun 2001 B1
6254623 Haibel, Jr. et al. Jul 2001 B1
6257241 Wampler Jul 2001 B1
6258085 Eggleston Jul 2001 B1
6261286 Goble et al. Jul 2001 B1
6267761 Ryan Jul 2001 B1
6270497 Sekino et al. Aug 2001 B1
6273862 Privitera et al. Aug 2001 B1
6277114 Bullivant et al. Aug 2001 B1
6277115 Saadat Aug 2001 B1
6277117 Tetzlaff et al. Aug 2001 B1
6280398 Ritchart et al. Aug 2001 B1
6280407 Manna et al. Aug 2001 B1
6280441 Ryan Aug 2001 B1
6283963 Regula Sep 2001 B1
6287344 Wampler Sep 2001 B1
6293942 Goble et al. Sep 2001 B1
6293945 Parins et al. Sep 2001 B1
6296637 Thorne et al. Oct 2001 B1
6296640 Wampler et al. Oct 2001 B1
6298550 Kirwan, Jr. Oct 2001 B1
6302903 Mulier et al. Oct 2001 B1
6306131 Hareyama et al. Oct 2001 B1
6306134 Goble et al. Oct 2001 B1
6308089 von der Ruhr et al. Oct 2001 B1
6309400 Beaupre Oct 2001 B2
6312426 Goldberg et al. Nov 2001 B1
6315777 Comben Nov 2001 B1
6319221 Savage et al. Nov 2001 B1
6322494 Bullivant et al. Nov 2001 B1
6322549 Eggers et al. Nov 2001 B1
6322561 Eggers et al. Nov 2001 B1
6325795 Lindemann et al. Dec 2001 B1
6325799 Goble Dec 2001 B1
6325811 Messerly Dec 2001 B1
6328736 Mulier et al. Dec 2001 B1
6328751 Beaupre Dec 2001 B1
6331181 Tierney et al. Dec 2001 B1
6334068 Hacker Dec 2001 B1
6334861 Chandler et al. Jan 2002 B1
6336926 Goble Jan 2002 B1
6348051 Farin et al. Feb 2002 B1
6352532 Kramer et al. Mar 2002 B1
6352536 Buysse et al. Mar 2002 B1
6358248 Mulier et al. Mar 2002 B1
6358249 Chen et al. Mar 2002 B1
6358267 Murakami Mar 2002 B1
6361534 Chen et al. Mar 2002 B1
6364877 Goble et al. Apr 2002 B1
6364879 Chen et al. Apr 2002 B1
6371967 Long et al. Apr 2002 B1
D457958 Dycus et al. May 2002 S
6383183 Sekino et al. May 2002 B1
6387092 Burnside et al. May 2002 B1
6387109 Davison et al. May 2002 B1
6391024 Sun et al. May 2002 B1
6391025 Weinstein et al. May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6398781 Goble et al. Jun 2002 B1
6402741 Keppel et al. Jun 2002 B1
6402742 Blewett et al. Jun 2002 B1
6402743 Orszulak et al. Jun 2002 B1
6402747 Lindemann et al. Jun 2002 B1
6402748 Schoenman et al. Jun 2002 B1
6406475 Wenzler et al. Jun 2002 B1
6409722 Hoey et al. Jun 2002 B1
6409724 Penny et al. Jun 2002 B1
6409728 Ehr et al. Jun 2002 B1
6416486 Wampler Jul 2002 B1
6416509 Goble et al. Jul 2002 B1
6423057 He et al. Jul 2002 B1
6423082 Houser et al. Jul 2002 B1
6432118 Messerly Aug 2002 B1
6436096 Hareyama Aug 2002 B1
6440130 Mulier et al. Aug 2002 B1
6443952 Mulier et al. Sep 2002 B1
6443968 Holthaus et al. Sep 2002 B1
6443970 Schulze et al. Sep 2002 B1
6451013 Bays et al. Sep 2002 B1
6451018 Lands et al. Sep 2002 B1
6454764 Fleenor et al. Sep 2002 B1
6454781 Witt et al. Sep 2002 B1
6454782 Schwemberger Sep 2002 B1
6458078 Lüdtke et al. Oct 2002 B1
6458128 Schulze Oct 2002 B1
6458130 Frazier et al. Oct 2002 B1
6458142 Faller et al. Oct 2002 B1
6461352 Morgan et al. Oct 2002 B2
6464689 Qin et al. Oct 2002 B1
6464702 Schulze et al. Oct 2002 B2
6464704 Schmaltz et al. Oct 2002 B2
6468275 Wampler et al. Oct 2002 B1
6468286 Mastri et al. Oct 2002 B2
6475217 Platt Nov 2002 B1
6478030 Shapeton et al. Nov 2002 B1
6482202 Goble et al. Nov 2002 B1
6485490 Wampler et al. Nov 2002 B2
6488507 Stoloff et al. Dec 2002 B1
6488680 Francischelli et al. Dec 2002 B1
6491690 Goble et al. Dec 2002 B1
6491708 Madan et al. Dec 2002 B2
6493589 Medhkour et al. Dec 2002 B1
6494877 Odell et al. Dec 2002 B2
6494902 Hoey et al. Dec 2002 B2
6497705 Comben Dec 2002 B2
6500176 Truckai et al. Dec 2002 B1
6500188 Harper et al. Dec 2002 B2
6503263 Adams Jan 2003 B2
6506189 Rittman, III et al. Jan 2003 B1
6506208 Hunt et al. Jan 2003 B2
6510854 Goble et al. Jan 2003 B2
6511476 Hareyama Jan 2003 B2
6511480 Tetzlaff et al. Jan 2003 B1
6514252 Nezhat et al. Feb 2003 B2
6517536 Hooven et al. Feb 2003 B2
6517538 Jacob et al. Feb 2003 B1
6526320 Mitchell Feb 2003 B2
6527771 Weadock et al. Mar 2003 B1
6533784 Truckai et al. Mar 2003 B2
6534770 Miller et al. Mar 2003 B2
6537248 Mulier et al. Mar 2003 B2
6537272 Christopherson et al. Mar 2003 B2
6540695 Burbank et al. Apr 2003 B1
6543456 Freeman Apr 2003 B1
6547783 Vilendrer et al. Apr 2003 B1
6547786 Goble et al. Apr 2003 B1
6554829 Schulze et al. Apr 2003 B2
6558379 Batchelor et al. May 2003 B1
6558383 Cunningham et al. May 2003 B2
6561983 Cronin et al. May 2003 B2
6562037 Paton et al. May 2003 B2
6565559 Eggleston May 2003 B2
6565560 Goble et al. May 2003 B1
6569105 Kurtenbach et al. May 2003 B1
6569109 Sakurai et al. May 2003 B2
6572615 Schulze et al. Jun 2003 B2
6579289 Schnitzler Jun 2003 B2
6582424 Fleenor et al. Jun 2003 B2
6582427 Goble et al. Jun 2003 B1
6584360 Francischelli et al. Jun 2003 B2
D477408 Bromley Jul 2003 S
6585732 Mulier et al. Jul 2003 B2
6585733 Wellman Jul 2003 B2
6585735 Frazier et al. Jul 2003 B1
6589200 Schwemberger et al. Jul 2003 B1
6591719 Poole et al. Jul 2003 B1
6592582 Hess et al. Jul 2003 B2
6594518 Benaron et al. Jul 2003 B1
6602227 Cimino et al. Aug 2003 B1
6602249 Stoddard et al. Aug 2003 B1
6602252 Mollenauer Aug 2003 B2
6605036 Wild Aug 2003 B1
6607529 Jones et al. Aug 2003 B1
6610060 Mulier et al. Aug 2003 B2
6611793 Burnside et al. Aug 2003 B1
6613048 Mulier et al. Sep 2003 B2
6616656 Brommersma Sep 2003 B2
6616660 Platt Sep 2003 B1
6616661 Wellman et al. Sep 2003 B2
6620157 Dabney et al. Sep 2003 B1
6620161 Schulze et al. Sep 2003 B2
6623482 Pendekanti et al. Sep 2003 B2
6623515 Mulier et al. Sep 2003 B2
6626901 Treat et al. Sep 2003 B1
6629974 Penny et al. Oct 2003 B2
6638274 Yamamoto Oct 2003 B2
6648883 Francischelli et al. Nov 2003 B2
6652514 Ellman et al. Nov 2003 B2
6652521 Schulze Nov 2003 B2
6656110 Irion et al. Dec 2003 B1
6656175 Francischelli et al. Dec 2003 B2
6656176 Hess et al. Dec 2003 B2
6656177 Truckai et al. Dec 2003 B2
6660017 Beaupre Dec 2003 B2
6662050 Olson Dec 2003 B2
6662127 Wiener et al. Dec 2003 B2
6663622 Foley et al. Dec 2003 B1
6663627 Francischelli et al. Dec 2003 B2
6663628 Peters Dec 2003 B2
6666865 Platt Dec 2003 B2
6676660 Wampler et al. Jan 2004 B2
6678621 Wiener et al. Jan 2004 B2
6679882 Kornerup Jan 2004 B1
6682527 Strul Jan 2004 B2
6682528 Frazier et al. Jan 2004 B2
6682544 Mastri et al. Jan 2004 B2
6685701 Orszulak et al. Feb 2004 B2
6685703 Pearson et al. Feb 2004 B2
6692450 Coleman Feb 2004 B1
6692489 Heim et al. Feb 2004 B1
6695837 Howell Feb 2004 B2
6695838 Wellman et al. Feb 2004 B2
6695840 Schulze Feb 2004 B2
6699240 Francischelli Mar 2004 B2
6706038 Francischelli et al. Mar 2004 B2
6706039 Mulier et al. Mar 2004 B2
6709432 Ferek-Petric Mar 2004 B2
6723091 Goble et al. Apr 2004 B2
6726683 Shaw Apr 2004 B1
6726686 Buysse et al. Apr 2004 B2
6733498 Paton et al. May 2004 B2
6736810 Hoey et al. May 2004 B2
6740084 Ryan May 2004 B2
6740085 Hareyama et al. May 2004 B2
6740102 Hess et al. May 2004 B2
6743229 Buysse et al. Jun 2004 B2
6752804 Simpson et al. Jun 2004 B2
6755825 Schoenman et al. Jun 2004 B2
6755827 Mulier et al. Jun 2004 B2
6755841 Fraser et al. Jun 2004 B2
6758846 Goble et al. Jul 2004 B2
6764487 Mulier et al. Jul 2004 B2
6770071 Woloszko et al. Aug 2004 B2
6770072 Truckai et al. Aug 2004 B1
6773409 Truckai et al. Aug 2004 B2
6773434 Ciarrocca Aug 2004 B2
6773435 Schulze et al. Aug 2004 B2
6773444 Messerly Aug 2004 B2
6775575 Bommannan et al. Aug 2004 B2
6776780 Mulier et al. Aug 2004 B2
6780180 Goble et al. Aug 2004 B1
6786906 Cobb Sep 2004 B1
6790217 Schulze et al. Sep 2004 B2
6796828 Ehr et al. Sep 2004 B2
6796981 Wham et al. Sep 2004 B2
6807444 Tu et al. Oct 2004 B2
6807968 Francischelli et al. Oct 2004 B2
6808518 Wellman et al. Oct 2004 B2
6808525 Latterell et al. Oct 2004 B2
6814745 Prestel Nov 2004 B2
6821273 Mollenauer Nov 2004 B2
6827715 Francischelli et al. Dec 2004 B2
6827717 Brommersma et al. Dec 2004 B2
6827725 Batchelor et al. Dec 2004 B2
6830569 Thompson et al. Dec 2004 B2
6832111 Tu et al. Dec 2004 B2
6832985 Irion et al. Dec 2004 B2
6832998 Goble Dec 2004 B2
6835082 Gonnering Dec 2004 B2
6835195 Schulze et al. Dec 2004 B2
6837887 Woloszko et al. Jan 2005 B2
6843789 Goble Jan 2005 B2
6849073 Hoey et al. Feb 2005 B2
6852112 Platt Feb 2005 B2
6855142 Harano et al. Feb 2005 B2
6855145 Ciarrocca Feb 2005 B2
6858028 Mulier et al. Feb 2005 B2
6860881 Sturm et al. Mar 2005 B2
6860894 Pittman Mar 2005 B1
6887240 Lands et al. May 2005 B1
6889694 Hooven May 2005 B2
6893435 Goble May 2005 B2
6893441 Brommersma et al. May 2005 B2
6899710 Hooven May 2005 B2
6905497 Truckai et al. Jun 2005 B2
6905498 Hooven Jun 2005 B2
6908472 Wiener et al. Jun 2005 B2
6911019 Mulier et al. Jun 2005 B2
6913579 Truckai et al. Jul 2005 B2
6916318 Francischelli et al. Jul 2005 B2
6918880 Brookner et al. Jul 2005 B2
6923803 Goble Aug 2005 B2
6923804 Eggers et al. Aug 2005 B2
6923806 Hooven et al. Aug 2005 B2
6926716 Baker et al. Aug 2005 B2
6929641 Goble et al. Aug 2005 B2
6929644 Truckai et al. Aug 2005 B2
6932810 Ryan Aug 2005 B2
6932811 Hooven et al. Aug 2005 B2
6937033 Boronkay et al. Aug 2005 B2
6939347 Thompson Sep 2005 B2
6942660 Pantera et al. Sep 2005 B2
6942662 Goble et al. Sep 2005 B2
6945972 Frigg et al. Sep 2005 B2
6945981 Donofrio et al. Sep 2005 B2
6948503 Refior et al. Sep 2005 B2
6949098 Mulier et al. Sep 2005 B2
6958063 Soll et al. Oct 2005 B1
6960209 Clague et al. Nov 2005 B2
6960210 Lands et al. Nov 2005 B2
6962587 Johnson et al. Nov 2005 B2
6962589 Mulier et al. Nov 2005 B2
6966907 Goble Nov 2005 B2
6966909 Marshall et al. Nov 2005 B2
6971988 Orban, III Dec 2005 B2
6974453 Woloszko et al. Dec 2005 B2
6974454 Hooven Dec 2005 B2
6976969 Messerly Dec 2005 B2
6979332 Adams Dec 2005 B2
6984231 Goble et al. Jan 2006 B2
6984233 Hooven Jan 2006 B2
6984826 Miller et al. Jan 2006 B2
6989010 Francischelli et al. Jan 2006 B2
6994705 Nobis et al. Feb 2006 B2
6997735 Ehr et al. Feb 2006 B2
6997935 Anderson et al. Feb 2006 B2
7001380 Goble Feb 2006 B2
7001415 Hooven Feb 2006 B2
7011657 Truckai et al. Mar 2006 B2
7025764 Paton et al. Apr 2006 B2
7029470 Francischelli et al. Apr 2006 B2
7033351 Howell Apr 2006 B2
7033354 Keppel Apr 2006 B2
7033356 Latterell et al. Apr 2006 B2
7041096 Malis et al. May 2006 B2
7041102 Truckai et al. May 2006 B2
7044948 Keppel May 2006 B2
7044949 Orszulak et al. May 2006 B2
7044950 Yamamoto May 2006 B2
7048687 Reuss et al. May 2006 B1
7049599 Miller et al. May 2006 B2
7052494 Goble et al. May 2006 B2
7060063 Marion et al. Jun 2006 B2
7063699 Hess et al. Jun 2006 B2
7066933 Hagg Jun 2006 B2
7066936 Ryan Jun 2006 B2
7070597 Truckai et al. Jul 2006 B2
7074218 Washington et al. Jul 2006 B2
7074219 Levine et al. Jul 2006 B2
7083618 Couture et al. Aug 2006 B2
7083619 Truckai et al. Aug 2006 B2
7083620 Jahns et al. Aug 2006 B2
7087054 Truckai et al. Aug 2006 B2
7090673 Dycus et al. Aug 2006 B2
7094202 Nobis et al. Aug 2006 B2
7094235 Francischelli Aug 2006 B2
7097644 Long Aug 2006 B2
7101371 Dycus et al. Sep 2006 B2
7101372 Dycus et al. Sep 2006 B2
7101373 Dycus et al. Sep 2006 B2
7103947 Sartor et al. Sep 2006 B2
7104834 Robinson et al. Sep 2006 B2
7104989 Skarda Sep 2006 B2
7108695 Witt et al. Sep 2006 B2
7111769 Wales et al. Sep 2006 B2
7112201 Truckai et al. Sep 2006 B2
RE39358 Goble Oct 2006 E
7116157 Ross et al. Oct 2006 B2
7118564 Ritchie et al. Oct 2006 B2
7118570 Tetzlaff et al. Oct 2006 B2
7118587 Dycus et al. Oct 2006 B2
7119516 Denning Oct 2006 B2
7124932 Isaacson Oct 2006 B2
7125409 Truckai et al. Oct 2006 B2
7126125 Miller et al. Oct 2006 B2
7131445 Amoah Nov 2006 B2
7131860 Sartor et al. Nov 2006 B2
7131970 Moses et al. Nov 2006 B2
7131971 Dycus et al. Nov 2006 B2
7135018 Ryan et al. Nov 2006 B2
7135020 Lawes et al. Nov 2006 B2
7137980 Buysse et al. Nov 2006 B2
D533942 Kerr et al. Dec 2006 S
7147635 Ciarrocca Dec 2006 B2
7147637 Goble Dec 2006 B2
7147638 Chapman et al. Dec 2006 B2
7150097 Sremcich et al. Dec 2006 B2
7150748 Ebbutt et al. Dec 2006 B2
7150749 Dycus et al. Dec 2006 B2
7153300 Goble Dec 2006 B2
7156843 Skarda Jan 2007 B2
7156845 Mulier et al. Jan 2007 B2
7156846 Dycus et al. Jan 2007 B2
7159750 Racenet et al. Jan 2007 B2
7160293 Sturm et al. Jan 2007 B2
7160298 Lawes et al. Jan 2007 B2
7160299 Baily Jan 2007 B2
7163548 Stulen et al. Jan 2007 B2
7166105 Muller et al. Jan 2007 B2
7169115 Nobis et al. Jan 2007 B2
7169144 Hoey et al. Jan 2007 B2
7169145 Isaacson et al. Jan 2007 B2
7169146 Truckai et al. Jan 2007 B2
7172591 Harano et al. Feb 2007 B2
7179254 Pendkanti et al. Feb 2007 B2
7179258 Buysse et al. Feb 2007 B2
7182604 Ehr et al. Feb 2007 B2
7186252 Nobis et al. Mar 2007 B2
7186253 Truckai et al. Mar 2007 B2
7187790 Sabol et al. Mar 2007 B2
7189231 Clague et al. Mar 2007 B2
7189232 Scholl et al. Mar 2007 B2
7189233 Truckai et al. Mar 2007 B2
7191015 Lamson et al. Mar 2007 B2
7195627 Amoah et al. Mar 2007 B2
7195630 Ciarrocca Mar 2007 B2
7195631 Dumbauld Mar 2007 B2
7204835 Latterell et al. Apr 2007 B2
7207471 Heinrich et al. Apr 2007 B2
7207990 Lands et al. Apr 2007 B2
D541938 Kerr et al. May 2007 S
7211081 Goble May 2007 B2
7211084 Goble et al. May 2007 B2
7214224 Goble May 2007 B2
7216001 Hacker et al. May 2007 B2
7220260 Fleming et al. May 2007 B2
7220951 Truckai et al. May 2007 B2
7223239 Schulze et al. May 2007 B2
7223265 Keppel May 2007 B2
7226447 Uchida et al. Jun 2007 B2
7229307 Ehr et al. Jun 2007 B2
7232439 Ciarrocca Jun 2007 B2
7232440 Dumbald et al. Jun 2007 B2
7235048 Rein et al. Jun 2007 B2
7235072 Sartor et al. Jun 2007 B2
7235073 Levine et al. Jun 2007 B2
7237708 Guy et al. Jul 2007 B1
7241296 Buysse et al. Jul 2007 B2
7247141 Makin et al. Jul 2007 B2
7247155 Hoey et al. Jul 2007 B2
7250048 Francischelli et al. Jul 2007 B2
7250051 Francischelli Jul 2007 B2
7252667 Moses et al. Aug 2007 B2
7255694 Keppel Aug 2007 B2
7255696 Goble et al. Aug 2007 B2
7255697 Dycus et al. Aug 2007 B2
7259340 Blaha et al. Aug 2007 B2
7261711 Mulier et al. Aug 2007 B2
7267677 Johnson et al. Sep 2007 B2
7270660 Ryan Sep 2007 B2
7270664 Johnson et al. Sep 2007 B2
7273483 Weiner et al. Sep 2007 B2
7276068 Johnson et al. Oct 2007 B2
7278994 Goble Oct 2007 B2
7282048 Goble et al. Oct 2007 B2
7282049 Oraszulak et al. Oct 2007 B2
7291161 Hooven Nov 2007 B2
7297145 Woloszko et al. Nov 2007 B2
7300435 Wham et al. Nov 2007 B2
7300446 Beaupre Nov 2007 B2
7300450 Vleugels et al. Nov 2007 B2
7303557 Wham et al. Dec 2007 B2
7309325 Mulier et al. Dec 2007 B2
7309849 Truckai et al. Dec 2007 B2
7311560 Ehr et al. Dec 2007 B2
7311706 Schoenman et al. Dec 2007 B2
7311707 Hagg et al. Dec 2007 B2
7311709 Truckai et al. Dec 2007 B2
7322975 Goble et al. Jan 2008 B2
7329256 Johnson et al. Feb 2008 B2
7335997 Weiner Feb 2008 B2
7344532 Goble et al. Mar 2008 B2
7347858 Francischelli et al. Mar 2008 B2
RE40279 Sluijter et al. Apr 2008 E
D567943 Moses et al. Apr 2008 S
7353068 Tanaka et al. Apr 2008 B2
7354435 Farin et al. Apr 2008 B2
7354440 Truckal et al. Apr 2008 B2
7354443 Moll et al. Apr 2008 B2
7364577 Wham et al. Apr 2008 B2
7364578 Francischelli et al. Apr 2008 B2
7364579 Mulier et al. Apr 2008 B2
7367972 Francischelli et al. May 2008 B2
7367976 Lawes et al. May 2008 B2
7371246 Viola May 2008 B2
7377902 Burbank et al. May 2008 B2
7377918 Amoah May 2008 B2
7377920 Buysse et al. May 2008 B2
RE40388 Gines Jun 2008 E
7381209 Truckai et al. Jun 2008 B2
7384420 Dycus et al. Jun 2008 B2
7384421 Hushka Jun 2008 B2
7396336 Orszulak et al. Jul 2008 B2
D575395 Hushka Aug 2008 S
D575401 Hixson et al. Aug 2008 S
7416101 Shelton, IV et al. Aug 2008 B2
7416437 Sartor et al. Aug 2008 B2
7419487 Johnson et al. Sep 2008 B2
7422139 Shelton, IV et al. Sep 2008 B2
7422588 Mulier et al. Sep 2008 B2
7424965 Racenet et al. Sep 2008 B2
7425835 Eisele Sep 2008 B2
7426415 Kühner Sep 2008 B2
7431720 Pendekanti et al. Oct 2008 B2
7431721 Paton et al. Oct 2008 B2
7435249 Buysse et al. Oct 2008 B2
7435250 Francischelli et al. Oct 2008 B2
7442167 Dunki-Jacobs et al. Oct 2008 B2
7442193 Shields et al. Oct 2008 B2
7442194 Dumbauld et al. Oct 2008 B2
7445621 Dumbauld et al. Nov 2008 B2
7458972 Keppel Dec 2008 B2
7464846 Shelton, IV et al. Dec 2008 B2
7470272 Mulier et al. Dec 2008 B2
7473250 Makin et al. Jan 2009 B2
7473253 Dycus et al. Jan 2009 B2
7476233 Wiener et al. Jan 2009 B1
7481808 Koyfman et al. Jan 2009 B2
7491199 Goble Feb 2009 B2
7497858 Chapelon et al. Mar 2009 B2
7811283 Moses et al. Oct 2010 B2
7841765 Keller Nov 2010 B2
8561615 Pannell et al. Oct 2013 B2
8784417 Hanna Jul 2014 B2
8808288 Rescheke Aug 2014 B2
20010037110 Schmaltz et al. Nov 2001 A1
20010039417 Harano et al. Nov 2001 A1
20020052599 Goble May 2002 A1
20020107517 Witt Aug 2002 A1
20020115997 Truckai et al. Aug 2002 A1
20020120262 Bek et al. Aug 2002 A1
20020120266 Truckai et al. Aug 2002 A1
20020128650 McClurken Sep 2002 A1
20020161363 Fodor et al. Oct 2002 A1
20020165541 Whitman Nov 2002 A1
20020188294 Couture et al. Dec 2002 A1
20030004510 Wham et al. Jan 2003 A1
20030014052 Buysse et al. Jan 2003 A1
20030065327 Wellman et al. Apr 2003 A1
20030065358 Frecker et al. Apr 2003 A1
20030069571 Treat et al. Apr 2003 A1
20030109871 Johnson et al. Jun 2003 A1
20030114845 Paton et al. Jun 2003 A1
20030114848 Cobb Jun 2003 A1
20030114851 Truckai et al. Jun 2003 A1
20030125728 Nezhat et al. Jul 2003 A1
20030125731 Smith et al. Jul 2003 A1
20030125734 Mollenauer Jul 2003 A1
20030139741 Goble et al. Jul 2003 A1
20030181910 Dycus et al. Sep 2003 A1
20030199863 Swanson et al. Oct 2003 A1
20030199870 Truckai et al. Oct 2003 A1
20030229344 Dycus et al. Dec 2003 A1
20030236549 Bonadio et al. Dec 2003 A1
20040006340 Latterell et al. Jan 2004 A1
20040068274 Hooven Apr 2004 A1
20040068304 Paton et al. Apr 2004 A1
20040073247 Loshakove et al. Apr 2004 A1
20040082946 Malis et al. Apr 2004 A1
20040092922 Kadziauskas et al. May 2004 A1
20040122423 Dycus et al. Jun 2004 A1
20040162557 Tetzlaff et al. Aug 2004 A1
20040193148 Wham et al. Sep 2004 A1
20040215127 Kadziauskas et al. Oct 2004 A1
20040225288 Buysse et al. Nov 2004 A1
20040250419 Sremich et al. Dec 2004 A1
20050004563 Racz et al. Jan 2005 A1
20050004564 Wham et al. Jan 2005 A1
20050021027 Shields et al. Jan 2005 A1
20050033282 Hooven Feb 2005 A1
20050033352 Zepf et al. Feb 2005 A1
20050080319 Dinkler, II et al. Apr 2005 A1
20050090815 Francischelli et al. Apr 2005 A1
20050096681 Desinger et al. May 2005 A1
20050101951 Wham et al. May 2005 A1
20050107785 Dycus et al. May 2005 A1
20050113817 Isaacson et al. May 2005 A1
20050113819 Wham May 2005 A1
20050124915 Eggers et al. Jun 2005 A1
20050137592 Nguyen et al. Jun 2005 A1
20050149017 Dycus Jul 2005 A1
20050159745 Truckai et al. Jul 2005 A1
20050165444 Hart et al. Jul 2005 A1
20050192568 Truckai et al. Sep 2005 A1
20050203504 Wham et al. Sep 2005 A1
20050234447 Paton et al. Oct 2005 A1
20050245918 Sliwa, Jr. et al. Nov 2005 A1
20050245922 Goble Nov 2005 A1
20060020265 Ryan Jan 2006 A1
20060041254 Francischelli et al. Feb 2006 A1
20060052777 Dumbauld Mar 2006 A1
20060079788 Anderson et al. Apr 2006 A1
20060079878 Houser Apr 2006 A1
20060129146 Dycus et al. Jun 2006 A1
20060161190 Gadberry et al. Jul 2006 A1
20060167450 Johnson et al. Jul 2006 A1
20060173453 Gruhl et al. Aug 2006 A1
20060217697 Lau et al. Sep 2006 A1
20060217706 Lau et al. Sep 2006 A1
20060217707 Daniel et al. Sep 2006 A1
20060224152 Behnke et al. Oct 2006 A1
20060224158 Odom et al. Oct 2006 A1
20060247498 Bonadio et al. Nov 2006 A1
20060271042 Latterell et al. Nov 2006 A1
20070016185 Tullis et al. Jan 2007 A1
20070043352 Garrison et al. Feb 2007 A1
20070043353 Dycus et al. Feb 2007 A1
20070062017 Dycus et al. Mar 2007 A1
20070088202 Albrecht et al. Apr 2007 A1
20070090788 Hansford et al. Apr 2007 A1
20070093800 Wham et al. Apr 2007 A1
20070123847 Mihori May 2007 A1
20070135811 Hooven Jun 2007 A1
20070142833 Dycus et al. Jun 2007 A1
20070142834 Dumbauld Jun 2007 A1
20070156139 Schecter et al. Jul 2007 A1
20070156140 Baily Jul 2007 A1
20070167941 Hamel et al. Jul 2007 A1
20070173811 Couture et al. Jul 2007 A1
20070173813 Odom Jul 2007 A1
20070173814 Hixson et al. Jul 2007 A1
20070179499 Garrison Aug 2007 A1
20070191827 Lischinsky et al. Aug 2007 A1
20070191828 Houser et al. Aug 2007 A1
20070203481 Gregg et al. Aug 2007 A1
20070213712 Buysse et al. Sep 2007 A1
20070260242 Dycus et al. Nov 2007 A1
20070276363 Patton et al. Nov 2007 A1
20070282195 Masini et al. Dec 2007 A1
20070282320 Buysse et al. Dec 2007 A1
20070282332 Witt et al. Dec 2007 A1
20070287997 Tolmei Dec 2007 A1
20080009860 Odom Jan 2008 A1
20080015563 Hoey et al. Jan 2008 A1
20080015564 Wham et al. Jan 2008 A1
20080030206 Podhajsky et al. Feb 2008 A1
20080039831 Odom et al. Feb 2008 A1
20080045947 Johnson et al. Feb 2008 A1
20080058802 Couture et al. Mar 2008 A1
20080082098 Tanaka et al. Apr 2008 A1
20080091189 Carlton Apr 2008 A1
20080114356 Johnson et al. May 2008 A1
20080125772 Stone et al. May 2008 A1
20080132893 D'Amelio et al. Jun 2008 A1
20080167651 Tetzlaff et al. Jul 2008 A1
20080172048 Martin et al. Jul 2008 A1
20080188848 Deutmeyer et al. Aug 2008 A1
20080208246 Livneh Aug 2008 A1
20080215050 Bakos Sep 2008 A1
20080215051 Buysse et al. Sep 2008 A1
20080228179 Eder et al. Sep 2008 A1
20080294222 Schecter Nov 2008 A1
20080300589 Paul et al. Dec 2008 A1
20080300590 Horne et al. Dec 2008 A1
20080300591 Darian et al. Dec 2008 A1
20090012520 Hixson et al. Jan 2009 A1
20090024126 Artale et al. Jan 2009 A1
20090248007 Falkenstein Oct 2009 A1
20090275490 Milne et al. Nov 2009 A1
20090275940 Malackowski et al. Nov 2009 A1
20120010614 Couture Jan 2012 A1
20120059371 Anderson et al. Mar 2012 A1
20120083785 Roy et al. Apr 2012 A1
20120136347 Brustad et al. May 2012 A1
20120197243 Sherman et al. Aug 2012 A1
20120215220 Manzo et al. Aug 2012 A1
20120265196 Turner Oct 2012 A1
20130018411 Collings et al. Jan 2013 A1
20130138101 Kerr May 2013 A1
20130274743 Banfalvi Oct 2013 A1
20130296843 Boudrequx et al. Nov 2013 A1
20140005658 Rosenbegr Jan 2014 A1
20140088583 Singh Mar 2014 A1
20140214019 Baxter, III et al. Jul 2014 A1
Foreign Referenced Citations (55)
Number Date Country
0 315 338 May 1989 EP
0 538 984 Apr 1993 EP
0 598 202 May 1994 EP
0 717 967 Jun 1996 EP
0 737 447 Oct 1996 EP
0 878 168 Nov 1998 EP
1 054 637 Nov 2000 EP
1 535 581 Jun 2005 EP
1 545 361 Jun 2005 EP
1 557 129 Jul 2005 EP
1 634 539 Mar 2006 EP
1 634 539 Mar 2006 EP
1 665 995 Jun 2006 EP
1 728 475 Dec 2006 EP
1 810 628 Jul 2007 EP
1 946 715 Jul 2008 EP
2 106 762 Oct 2009 EP
2 111 812 Oct 2009 EP
2 156 802 Feb 2010 EP
2 340 792 Jul 2011 EP
2 436 330 Apr 2012 EP
2 157 175 Oct 1985 GB
2 462 453 Aug 2008 GB
83-17935 Dec 1996 JP
11-070123 Mar 1999 JP
11-070124 Mar 1999 JP
11-178833 Jul 1999 JP
2000-254135 Sep 2000 JP
2003-135481 May 2003 JP
2003-164463 Jun 2003 JP
2006-109945 Apr 2006 JP
2006-167403 Jun 2006 JP
2007-144201 Jun 2007 JP
2007-195980 Aug 2007 JP
2007-195985 Aug 2007 JP
2008-043789 Feb 2008 JP
2008-259864 Oct 2008 JP
WO 93015662 Aug 1993 WO
WO 97010764 Mar 1997 WO
WO 99040857 Aug 1999 WO
WO 01012090 Feb 2001 WO
WO 2004030553 Apr 2004 WO
WO 2004032776 Apr 2004 WO
WO 2004032777 Apr 2004 WO
WO 2004082495 Sep 2004 WO
WO 2005004735 Jan 2005 WO
WO 05053785 Jun 2005 WO
WO 2006119245 Nov 2006 WO
WO 2006125558 Nov 2006 WO
WO 2007044849 Apr 2007 WO
WO 2007142601 Dec 2007 WO
WO 2008147773 Dec 2008 WO
WO 2009065140 May 2009 WO
WO 2012110996 Aug 2012 WO
WO 2013030349 Mar 2013 WO
Non-Patent Literature Citations (30)
Entry
Bertil Vallfors and Bjorn Bergdahl, Automatically controlled bipolar electrocoagulation—“COA-COMP”, Neurosurg. Rev., 1984, pp. 187-190.
“New Products” Journal of Medical Engineering and Technology, vol. 19, No. 5 (Sep./Oct. 1995), pp. 189-190.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US09/39046 titled “Electrosurgical System,” dated Jul. 27, 2009, 31 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US09/39046, titled “Electrosurgical System,” dated Mar. 26, 2010, 18 pgs.
European Patent Office, European Search Report for European Application No. EP 10 19 2593, titled “Electrosurgical System,” dated Mar. 21, 2011, 8 pgs.
European Patent Office, European Search Report for European Application No. EP 10 19 2614, titled “Electrosurgical System,” dated Apr. 18, 2011, 7 pgs.
European Patent Office, Extended European Search Report for European Application No. EP 10 19 2580, dated Jul. 21, 2011, 6 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US09/39046, titled “Electrosurgical System,” dated Jan. 17, 2012, 45 pgs.
European Patent Office, European Search Report for European Patent Application No. 12151288, dated Feb. 10, 2012, 8 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2011/054661, dated Mar. 6, 2012, 23 pgs.
European Patent Office, Supplementary European Search Report for European Patent Application No. 08755322, dated Apr. 18, 2012, 3 pgs.
European Patent Office, Supplementary European Search Report for European Patent Application No. 08755322, dated Jun. 6, 2012, 2 pgs.
European Patent Office, Partial European Search Report for European Patent Application No. 15151398.3, dated Jun. 22, 2015, 9 pgs.
U.S. Appl. No. 12/611,352, filed Nov. 3, 2009, titled Tissue Fusion/Welder Apparatus and Method, now U.S. Pat. No. 8,551,089 issued Oct. 8, 2013.
U.S. Appl. No. 12/183,970, filed Jul. 31, 2008, entitled Bipolar Electrosurgical Scissors, now U.S. Pat. No. 8,226,649 issued Jul. 24, 2012.
U.S. Appl. No. 12/416,128, filed Mar. 31, 2009, entitled Electrosurgical System, now U.S. Pat. No. 8,568,411 issued Oct. 29, 2013.
US Patent Application No. PCT/US09/39046 filed Mar. 31, 2009, entitled Electrosurgical System.
U.S. Appl. No. 12/416,668, filed Apr. 1, 2009, entitled Electrosurgical System, now U.S. Pat. No. 8,562,598 issued Oct. 22, 2013.
U.S. Appl. No. 12/416,695, filed Apr. 1, 2009, entitled Electrosurgical System, now U.S. Pat. No. 8,551,088 issued Oct. 8, 2013.
U.S. Appl. No. 12/416,765, filed Apr. 1, 2009, entitled Electrosurgical System, now U.S. Pat. No. 8,915,910 issued Dec. 23, 2014.
U.S. Appl. No. 12/416,751, filed Apr. 1, 2009, entitled Electrosurgical System, now U.S. Pat. No. 8,579,894 issued Nov. 12, 2013.
The International Bureau of WIPO, The International Preliminary Report on Patentability for International Application No. PCT/US2011/054661, entitled “Electrosurgical Instruments and Connections Thereto,” dated Apr. 2, 2013, 10 pgs.
European Patent Office, European Search Report for European Application No. EP 13 17 4814.7, titled “Electrosurgical System,” dated Sep. 30, 2013, 4 pgs.
European Patent Office, European Search Report for European Patent Application No. EP 14199708.0, entitled “Electrosurgical System,” dated Jul. 10, 2015, 14 pgs.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2015/031452 ,titled “Electrosurgical Fusion Device,” dated Dec. 3, 2015, 27 pgs.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2015/066473 titled “Bipolar Electrosurgical Sealer and Divider.” dated Mar. 31, 2016, 13 pgs.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2015/033546 titled “Electrosurgical Seal and Dissection Systems.” dated Apr. 22, 2016, 31 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US2015/031452, titled “Electrosurgical System,” dated Dec. 1, 2016, 21 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US2015/033546, titled “Electrosurgical Laparoscopic Sealer and Dissector,” dated Dec. 15, 2016, 22 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US2015/0066473, titled “Bipolar Electrosurgical Sealer and Divider,” dated Jul. 6, 2017, 10 pgs.
Related Publications (1)
Number Date Country
20170042604 A1 Feb 2017 US
Provisional Applications (2)
Number Date Country
62004980 May 2014 US
62005009 May 2014 US
Continuations (1)
Number Date Country
Parent PCT/US2015/033546 Jun 2015 US
Child 15334102 US